Digoxin Injectionshould Only Be Prescribed in Secondary Care by Or

Report generated from Joint Formulary provided by FormularyComplete (www.pharmpress.com). Accessed 06 04 2017

TA Title Formulary Status Section TA Link Annotation Number

Specialist Digoxin injectionshould only be prescribed in secondary care by or under the explicit DIGOXIN 2.1 Positive inotropic drugs->2.1.1 Cardiac glycosides knowledge drugs direction of a specialist.

Specialist 2.1 Positive inotropic drugs->2.1.1 Cardiac Digoxin injectionshould only be prescribed in secondary care by or under the explicit Digoxin knowledge drugs glycosides->DIGOXIN direction of a specialist.

Specialist 2.1 Positive inotropic drugs->2.1.1 Cardiac Digoxin injectionshould only be prescribed in secondary care by or under the explicit Lanoxin® knowledge drugs glycosides->DIGOXIN direction of a specialist.

Specialist 2.1 Positive inotropic drugs->2.1.1 Cardiac Lanoxin-PG® knowledge drugs glycosides->DIGOXIN

Hospital only Digoxin-specific antibody 2.1 Positive inotropic drugs->2.1.1 Cardiac glycosides prescribing

Hospital only 2.1 Positive inotropic drugs->2.1.1 Cardiac DigiFab® prescribing glycosides->Digoxin-specific antibody

Phosphodiesterase type-3 Hospital only 2.1 Positive inotropic drugs inhibitors prescribing

Hospital only 2.1 Positive inotropic drugs->2.1.2 Phosphodiesterase ENOXIMONE prescribing type-3 inhibitors

Hospital only 2.1 Positive inotropic drugs->2.1.2 Phosphodiesterase Perfan® prescribing type-3 inhibitors->ENOXIMONE

Hospital only 2.1 Positive inotropic drugs->2.1.2 Phosphodiesterase MILRINONE prescribing type-3 inhibitors

Hospital only 2.1 Positive inotropic drugs->2.1.2 Phosphodiesterase Primacor® prescribing type-3 inhibitors->MILRINONE

Joint formulary BENDROFLUMETHIAZIDE 2.2 Diuretics->2.2.1 Thiazides and related diuretics choice

Joint formulary 2.2 Diuretics->2.2.1 Thiazides and related Bendroflumethiazide choice diuretics->BENDROFLUMETHIAZIDE

Bendroflumethiazide formulations Not approved for 2.2 Diuretics->2.2.1 Thiazides and related [unlicensed] prescribing diuretics->BENDROFLUMETHIAZIDE Joint formulary CHLORTALIDONE 2.2 Diuretics->2.2.1 Thiazides and related diuretics choice

Joint formulary 2.2 Diuretics->2.2.1 Thiazides and related Hygroton® choice diuretics->CHLORTALIDONE

Not approved for CYCLOPENTHIAZIDE 2.2 Diuretics->2.2.1 Thiazides and related diuretics prescribing

Not approved for 2.2 Diuretics->2.2.1 Thiazides and related Navidrex® prescribing diuretics->CYCLOPENTHIAZIDE

Joint formulary INDAPAMIDE 2.2 Diuretics->2.2.1 Thiazides and related diuretics choice

Joint formulary 2.2 Diuretics->2.2.1 Thiazides and related Indapamide choice diuretics->INDAPAMIDE

Joint formulary 2.2 Diuretics->2.2.1 Thiazides and related Natrilix® choice diuretics->INDAPAMIDE

Joint formulary 2.2 Diuretics->2.2.1 Thiazides and related Modified release choice diuretics->INDAPAMIDE

Joint formulary 2.2 Diuretics->2.2.1 Thiazides and related Ethibide XL® choice diuretics->INDAPAMIDE->Modified release

Joint formulary 2.2 Diuretics->2.2.1 Thiazides and related Natrilix SR® choice diuretics->INDAPAMIDE->Modified release

Joint formulary 2.2 Diuretics->2.2.1 Thiazides and related Tensaid XL® choice diuretics->INDAPAMIDE->Modified release

Specialist METOLAZONE 2.2 Diuretics->2.2.1 Thiazides and related diuretics knowledge drugs

Specialist 2.2 Diuretics->2.2.1 Thiazides and related Metolazone knowledge drugs diuretics->METOLAZONE

Not approved for XIPAMIDE 2.2 Diuretics->2.2.1 Thiazides and related diuretics prescribing

Not approved for 2.2 Diuretics->2.2.1 Thiazides and related Diurexan® prescribing diuretics->XIPAMIDE

Joint formulary BUMETANIDE 2.2 Diuretics->2.2.2 Loop diuretics choice

Joint formulary Bumetanide 2.2 Diuretics->2.2.2 Loop diuretics->BUMETANIDE choice Joint formulary Furosemideinjectionshould only be prescribed in secondary care by or under the explicit direction FUROSEMIDE 2.2 Diuretics->2.2.2 Loop diuretics choice of a specialist.

Joint formulary Furosemideinjectionshould only be prescribed in secondary care by or under the explicit direction Furosemide 2.2 Diuretics->2.2.2 Loop diuretics->FUROSEMIDE choice of a specialist.

Hospital only Lasix® 2.2 Diuretics->2.2.2 Loop diuretics->FUROSEMIDE prescribing

Not approved for TORASEMIDE 2.2 Diuretics->2.2.2 Loop diuretics prescribing

Not approved for Torasemide 2.2 Diuretics->2.2.2 Loop diuretics->TORASEMIDE prescribing

Not approved for Torem® 2.2 Diuretics->2.2.2 Loop diuretics->TORASEMIDE prescribing

Joint formulary 2.2 Diuretics->2.2.3 Potassium-sparing diuretics and AMILORIDE HYDROCHLORIDE choice aldosterone antagonists

Joint formulary 2.2 Diuretics->2.2.3 Potassium-sparing diuretics and Amiloride choice aldosterone antagonists->AMILORIDE HYDROCHLORIDE

Compound preparations with Not approved for 2.2 Diuretics->2.2.3 Potassium-sparing diuretics and thiazide or loop diuretics prescribing aldosterone antagonists->AMILORIDE HYDROCHLORIDE

Not approved for 2.2 Diuretics->2.2.3 Potassium-sparing diuretics and TRIAMTERENE prescribing aldosterone antagonists

Not approved for 2.2 Diuretics->2.2.3 Potassium-sparing diuretics and Triamterene prescribing aldosterone antagonists->TRIAMTERENE

Compound preparations with Not approved for 2.2 Diuretics->2.2.3 Potassium-sparing diuretics and thiazides or loop diuretics prescribing aldosterone antagonists->TRIAMTERENE

Specialist 2.2 Diuretics->2.2.3 Potassium-sparing diuretics and EPLERENONE knowledge drugs aldosterone antagonists->Aldosterone antagonists

2.2 Diuretics->2.2.3 Potassium-sparing diuretics and Specialist Inspra® aldosterone antagonists->Aldosterone knowledge drugs antagonists->EPLERENONE

Joint formulary 2.2 Diuretics->2.2.3 Potassium-sparing diuretics and SPIRONOLACTONE choice aldosterone antagonists->Aldosterone antagonists 2.2 Diuretics->2.2.3 Potassium-sparing diuretics and Joint formulary Spironolactone aldosterone antagonists->Aldosterone choice antagonists->SPIRONOLACTONE

2.2 Diuretics->2.2.3 Potassium-sparing diuretics and Joint formulary Aldactone® aldosterone antagonists->Aldosterone choice antagonists->SPIRONOLACTONE

2.2 Diuretics->2.2.3 Potassium-sparing diuretics and Not approved for With thiazides or loop diuretics aldosterone antagonists->Aldosterone prescribing antagonists->SPIRONOLACTONE

Potassium-sparing diuretics with Not approved for 2.2 Diuretics other diuretics prescribing

Not approved for 2.2 Diuretics->2.2.4 Potassium-sparing diuretics with CO-AMILOFRUSE prescribing other diuretics

Not approved for 2.2 Diuretics->2.2.4 Potassium-sparing diuretics with Co-amilofruse prescribing other diuretics->CO-AMILOFRUSE

Not approved for 2.2 Diuretics->2.2.4 Potassium-sparing diuretics with CO-AMILOZIDE prescribing other diuretics

Not approved for 2.2 Diuretics->2.2.4 Potassium-sparing diuretics with Co-amilozide prescribing other diuretics->CO-AMILOZIDE

Not approved for 2.2 Diuretics->2.2.4 Potassium-sparing diuretics with TRIAMTERENE WITH FUROSEMIDE prescribing other diuretics

Not approved for 2.2 Diuretics->2.2.4 Potassium-sparing diuretics with Frusene® prescribing other diuretics->TRIAMTERENE WITH FUROSEMIDE

Not approved for 2.2 Diuretics->2.2.4 Potassium-sparing diuretics with Amiloride with cyclopenthiazide prescribing other diuretics

Not approved for 2.2 Diuretics->2.2.4 Potassium-sparing diuretics with Navispare® prescribing other diuretics->Amiloride with cyclopenthiazide

Not approved for 2.2 Diuretics->2.2.4 Potassium-sparing diuretics with Amiloride with bumetanide prescribing other diuretics

Not approved for 2.2 Diuretics->2.2.4 Potassium-sparing diuretics with Amiloride with bumetanide prescribing other diuretics->Amiloride with bumetanide

Not approved for 2.2 Diuretics->2.2.4 Potassium-sparing diuretics with Triamterene with thiazides prescribing other diuretics Not approved for 2.2 Diuretics->2.2.4 Potassium-sparing diuretics with Co-triamterzide prescribing other diuretics->Triamterene with thiazides

Not approved for 2.2 Diuretics->2.2.4 Potassium-sparing diuretics with Dyazide® prescribing other diuretics->Triamterene with thiazides

Not approved for 2.2 Diuretics->2.2.4 Potassium-sparing diuretics with Kalspare® prescribing other diuretics->Triamterene with thiazides

Not approved for 2.2 Diuretics->2.2.4 Potassium-sparing diuretics with Spironolactone with thiazides prescribing other diuretics

Not approved for 2.2 Diuretics->2.2.4 Potassium-sparing diuretics with Co-flumactone prescribing other diuretics->Spironolactone with thiazides

Not approved for 2.2 Diuretics->2.2.4 Potassium-sparing diuretics with Spironolactone with loop diuretics prescribing other diuretics

Not approved for 2.2 Diuretics->2.2.4 Potassium-sparing diuretics with Lasilactone® prescribing other diuretics->Spironolactone with loop diuretics

Hospital only MANNITOL 2.2 Diuretics->2.2.5 Osmotic diuretics prescribing

Hospital only Mannitol 2.2 Diuretics->2.2.5 Osmotic diuretics->MANNITOL prescribing

Not approved for Mercurial diuretics 2.2 Diuretics prescribing

Not approved for Carbonic anhydrase inhibitors 2.2 Diuretics prescribing

Not approved for Diuretics with potassium 2.2 Diuretics prescribing

Not approved for Diumide-K Continus® 2.2 Diuretics->2.2.8 Diuretics with potassium prescribing

Hospital only Supraventricular arrhythmias 2.3 Anti-arrhythmic drugs->2.3.2 Drugs for arrhythmias prescribing

Hospital only 2.3 Anti-arrhythmic drugs->2.3.2 Drugs for ADENOSINE prescribing arrhythmias->Supraventricular arrhythmias

2.3 Anti-arrhythmic drugs->2.3.2 Drugs for Hospital only Adenosine arrhythmias->Supraventricular prescribing arrhythmias->ADENOSINE 2.3 Anti-arrhythmic drugs->2.3.2 Drugs for Hospital only Adenocor® arrhythmias->Supraventricular prescribing arrhythmias->ADENOSINE

2.3 Anti-arrhythmic drugs->2.3.2 Drugs for Hospital only Adenoscan® arrhythmias->Supraventricular prescribing arrhythmias->ADENOSINE

Hospital only 2.3 Anti-arrhythmic drugs->2.3.2 Drugs for DRONEDARONE TA197 http://www.nice.org.uk/TA197 prescribing arrhythmias->Supraventricular arrhythmias

2.3 Anti-arrhythmic drugs->2.3.2 Drugs for Hospital only Multaq® arrhythmias->Supraventricular prescribing arrhythmias->DRONEDARONE

2.3 Anti-arrhythmic drugs->2.3.2 Drugs for Specialist Parenteral amiodarone should only be prescribed in secondary care by or under the explicit AMIODARONE HYDROCHLORIDE arrhythmias->Supraventricular and ventricular knowledge drugs direction of a specialist. arrhythmias

2.3 Anti-arrhythmic drugs->2.3.2 Drugs for Specialist Amiodarone injection/infusionshould only be prescribed in secondary care by or under the explicit Amiodarone arrhythmias->Supraventricular and ventricular knowledge drugs direction of a specialist. arrhythmias->AMIODARONE HYDROCHLORIDE

2.3 Anti-arrhythmic drugs->2.3.2 Drugs for Specialist Amiodarone injection/infusionshould only be prescribed in secondary care by or under the explicit Cordarone X® arrhythmias->Supraventricular and ventricular knowledge drugs direction of a specialist. arrhythmias->AMIODARONE HYDROCHLORIDE

2.3 Anti-arrhythmic drugs->2.3.2 Drugs for Amiodarone hydrochloride Not approved for arrhythmias->Supraventricular and ventricular formulations [unlicensed] prescribing arrhythmias->AMIODARONE HYDROCHLORIDE

2.3 Anti-arrhythmic drugs->2.3.2 Drugs for Hospital only DISOPYRAMIDE arrhythmias->Supraventricular and ventricular prescribing arrhythmias

2.3 Anti-arrhythmic drugs->2.3.2 Drugs for Hospital only Disopyramide arrhythmias->Supraventricular and ventricular prescribing arrhythmias->DISOPYRAMIDE

2.3 Anti-arrhythmic drugs->2.3.2 Drugs for Hospital only Rythmodan® arrhythmias->Supraventricular and ventricular prescribing arrhythmias->DISOPYRAMIDE

2.3 Anti-arrhythmic drugs->2.3.2 Drugs for Hospital only Modified release arrhythmias->Supraventricular and ventricular prescribing arrhythmias->DISOPYRAMIDE 2.3 Anti-arrhythmic drugs->2.3.2 Drugs for Hospital only Rythmodan Retard® arrhythmias->Supraventricular and ventricular prescribing arrhythmias->DISOPYRAMIDE->Modified release

2.3 Anti-arrhythmic drugs->2.3.2 Drugs for Specialist IV flecainideshould only be prescribed in secondary care by or under the explicit direction of a FLECAINIDE ACETATE arrhythmias->Supraventricular and ventricular knowledge drugs specialist. arrhythmias

2.3 Anti-arrhythmic drugs->2.3.2 Drugs for Specialist Flecainide arrhythmias->Supraventricular and ventricular knowledge drugs arrhythmias->FLECAINIDE ACETATE

2.3 Anti-arrhythmic drugs->2.3.2 Drugs for Specialist IV flecainideshould only be prescribed in secondary care by or under the explicit direction of a Tambocor® arrhythmias->Supraventricular and ventricular knowledge drugs specialist. arrhythmias->FLECAINIDE ACETATE

2.3 Anti-arrhythmic drugs->2.3.2 Drugs for Specialist Modified release arrhythmias->Supraventricular and ventricular knowledge drugs arrhythmias->FLECAINIDE ACETATE

2.3 Anti-arrhythmic drugs->2.3.2 Drugs for Specialist Tambocor® XL arrhythmias->Supraventricular and ventricular knowledge drugs arrhythmias->FLECAINIDE ACETATE->Modified release

2.3 Anti-arrhythmic drugs->2.3.2 Drugs for Hospital only PROPAFENONE HYDROCHLORIDE arrhythmias->Supraventricular and ventricular prescribing arrhythmias

2.3 Anti-arrhythmic drugs->2.3.2 Drugs for Hospital only Arythmol® arrhythmias->Supraventricular and ventricular prescribing arrhythmias->PROPAFENONE HYDROCHLORIDE

Hospital only Ventricular arrhythmias 2.3 Anti-arrhythmic drugs->2.3.2 Drugs for arrhythmias prescribing

Hospital only 2.3 Anti-arrhythmic drugs->2.3.2 Drugs for LIDOCAINE HYDROCHLORIDE prescribing arrhythmias->Ventricular arrhythmias

2.3 Anti-arrhythmic drugs->2.3.2 Drugs for Hospital only Lidocaine arrhythmias->Ventricular arrhythmias->LIDOCAINE prescribing HYDROCHLORIDE

2.3 Anti-arrhythmic drugs->2.3.2 Drugs for Hospital only Minijet® Lignocaine arrhythmias->Ventricular arrhythmias->LIDOCAINE prescribing HYDROCHLORIDE

Specialist Parenteral propranolol should only be prescribed in secondary care by or under the PROPRANOLOL HYDROCHLORIDE 2.4 Beta-adrenoceptor blocking drugs knowledge drugs explicit direction of a specialist. Specialist 2.4 Beta-adrenoceptor blocking drugs->PROPRANOLOL Parenteral propranolol should only be prescribed in secondary care by or under the Propranolol knowledge drugs HYDROCHLORIDE explicit direction of a specialist.

2.4 Beta-adrenoceptor blocking drugs->PROPRANOLOL Propranolol m/r preparations None HYDROCHLORIDE->Modified release

Not approved for ACEBUTOLOL 2.4 Beta-adrenoceptor blocking drugs prescribing

Not approved for Sectral® 2.4 Beta-adrenoceptor blocking drugs->ACEBUTOLOL prescribing

Joint formulary ATENOLOL 2.4 Beta-adrenoceptor blocking drugs Parenteralatenolol is not approved for prescribing. choice

Joint formulary Atenolol 2.4 Beta-adrenoceptor blocking drugs->ATENOLOL choice

Joint formulary Tenormin® 2.4 Beta-adrenoceptor blocking drugs->ATENOLOL Parenteralatenolol is not approved for prescribing. choice

Not approved for With diuretic 2.4 Beta-adrenoceptor blocking drugs->ATENOLOL prescribing

Not approved for 2.4 Beta-adrenoceptor blocking Kalten® prescribing drugs->ATENOLOL->With diuretic

Not approved for With calcium-channel blocker 2.4 Beta-adrenoceptor blocking drugs->ATENOLOL prescribing

Not approved for 2.4 Beta-adrenoceptor blocking Beta-Adalat® prescribing drugs->ATENOLOL->With calcium-channel blocker

Not approved for 2.4 Beta-adrenoceptor blocking Tenif® prescribing drugs->ATENOLOL->With calcium-channel blocker

Specialist BISOPROLOL FUMARATE 2.4 Beta-adrenoceptor blocking drugs knowledge drugs

Specialist 2.4 Beta-adrenoceptor blocking drugs->BISOPROLOL Bisoprolol Fumarate knowledge drugs FUMARATE

Specialist 2.4 Beta-adrenoceptor blocking drugs->BISOPROLOL Cardicor® knowledge drugs FUMARATE

Specialist CARVEDILOL 2.4 Beta-adrenoceptor blocking drugs knowledge drugs Specialist Carvedilol 2.4 Beta-adrenoceptor blocking drugs->CARVEDILOL knowledge drugs

Not approved for CELIPROLOL HYDROCHLORIDE 2.4 Beta-adrenoceptor blocking drugs prescribing

Not approved for 2.4 Beta-adrenoceptor blocking drugs->CELIPROLOL Celiprolol prescribing HYDROCHLORIDE

Not approved for 2.4 Beta-adrenoceptor blocking drugs->CELIPROLOL Celectol® prescribing HYDROCHLORIDE

Not approved for CO-TENIDONE 2.4 Beta-adrenoceptor blocking drugs prescribing

Not approved for Co-tenidone 2.4 Beta-adrenoceptor blocking drugs->CO-TENIDONE prescribing

Not approved for Tenoret 50® 2.4 Beta-adrenoceptor blocking drugs->CO-TENIDONE prescribing

Not approved for Tenoretic® 2.4 Beta-adrenoceptor blocking drugs->CO-TENIDONE prescribing

Not approved for ESMOLOL HYDROCHLORIDE 2.4 Beta-adrenoceptor blocking drugs prescribing

Not approved for 2.4 Beta-adrenoceptor blocking drugs->ESMOLOL Brevibloc® prescribing HYDROCHLORIDE

Joint formulary Parenterallabetalol should only be prescribed in secondary care by or under the explicit direction LABETALOL HYDROCHLORIDE 2.4 Beta-adrenoceptor blocking drugs choice of a specialist.

Joint formulary 2.4 Beta-adrenoceptor blocking drugs->LABETALOL Parenterallabetalol should only be prescribed in secondary care by or under the explicit direction Labetalol Hydrochloride choice HYDROCHLORIDE of a specialist.

Joint formulary 2.4 Beta-adrenoceptor blocking drugs->LABETALOL Trandate® choice HYDROCHLORIDE

Labetalol hydrochloride Not approved for 2.4 Beta-adrenoceptor blocking drugs->LABETALOL formulations [unlicensed] prescribing HYDROCHLORIDE

Joint formulary Parenteralmetoprolol should only be prescribed in secondary care by or under the explicit METOPROLOL TARTRATE 2.4 Beta-adrenoceptor blocking drugs choice direction of a specialist.

Joint formulary 2.4 Beta-adrenoceptor blocking drugs->METOPROLOL Metoprolol Tartrate choice TARTRATE

Hospital only 2.4 Beta-adrenoceptor blocking drugs->METOPROLOL Betaloc® prescribing TARTRATE Joint formulary 2.4 Beta-adrenoceptor blocking drugs->METOPROLOL Lopresor® choice TARTRATE

Joint formulary 2.4 Beta-adrenoceptor blocking drugs->METOPROLOL Modified release choice TARTRATE

Joint formulary 2.4 Beta-adrenoceptor blocking drugs->METOPROLOL Lopresor SR® choice TARTRATE->Modified release

Metoprolol tartrate formulations Not approved for 2.4 Beta-adrenoceptor blocking drugs->METOPROLOL [unlicensed] prescribing TARTRATE

Not approved for NADOLOL 2.4 Beta-adrenoceptor blocking drugs prescribing

Not approved for Corgard® 2.4 Beta-adrenoceptor blocking drugs->NADOLOL prescribing

Not approved for NEBIVOLOL 2.4 Beta-adrenoceptor blocking drugs prescribing

Not approved for Nebivolol 2.4 Beta-adrenoceptor blocking drugs->NEBIVOLOL prescribing

Not approved for Nebilet® 2.4 Beta-adrenoceptor blocking drugs->NEBIVOLOL prescribing

Not approved for OXPRENOLOL HYDROCHLORIDE 2.4 Beta-adrenoceptor blocking drugs prescribing

Not approved for 2.4 Beta-adrenoceptor blocking drugs->OXPRENOLOL Oxprenolol prescribing HYDROCHLORIDE

Not approved for 2.4 Beta-adrenoceptor blocking drugs->OXPRENOLOL Modified release prescribing HYDROCHLORIDE

Not approved for 2.4 Beta-adrenoceptor blocking drugs->OXPRENOLOL Slow-Trasicor® prescribing HYDROCHLORIDE->Modified release

Not approved for PINDOLOL 2.4 Beta-adrenoceptor blocking drugs prescribing

Not approved for Pindolol 2.4 Beta-adrenoceptor blocking drugs->PINDOLOL prescribing

Not approved for Visken® 2.4 Beta-adrenoceptor blocking drugs->PINDOLOL prescribing

Not approved for With diuretic 2.4 Beta-adrenoceptor blocking drugs->PINDOLOL prescribing Not approved for 2.4 Beta-adrenoceptor blocking Viskaldix® prescribing drugs->PINDOLOL->With diuretic

Specialist SOTALOL HYDROCHLORIDE 2.4 Beta-adrenoceptor blocking drugs knowledge drugs

Specialist 2.4 Beta-adrenoceptor blocking drugs->SOTALOL Sotalol knowledge drugs HYDROCHLORIDE

Specialist 2.4 Beta-adrenoceptor blocking drugs->SOTALOL Beta-Cardone® knowledge drugs HYDROCHLORIDE

Specialist 2.4 Beta-adrenoceptor blocking drugs->SOTALOL Sotacor® knowledge drugs HYDROCHLORIDE

Sotalol hydrochloride formulations Not approved for 2.4 Beta-adrenoceptor blocking drugs->SOTALOL [unlicensed] prescribing HYDROCHLORIDE

Not approved for TIMOLOL MALEATE 2.4 Beta-adrenoceptor blocking drugs prescribing

2.4 Beta-adrenoceptor blocking drugs->TIMOLOL Timolol None MALEATE

Not approved for 2.4 Beta-adrenoceptor blocking drugs->TIMOLOL With diuretic prescribing MALEATE

Timolol with amiloride and Not approved for 2.4 Beta-adrenoceptor blocking drugs->TIMOLOL hydrochlorothiazide prescribing MALEATE->With diuretic

Not approved for 2.4 Beta-adrenoceptor blocking drugs->TIMOLOL Prestim® prescribing MALEATE->With diuretic

Hospital only 2.5 Hypertension and heart failure->2.5.1 Vasodilator AMBRISENTAN prescribing antihypertensive drugs

Hospital only 2.5 Hypertension and heart failure->2.5.1 Vasodilator Volibris® prescribing antihypertensive drugs->AMBRISENTAN

The JPG agreed not to approve this medicine for use at the Homerton University Hospital Hospital only 2.5 Hypertension and heart failure->2.5.1 Vasodilator BOSENTAN prescribing antihypertensive drugs Foundation Trust as the trust does not provide this specialist service.

The JPG agreed not to approve this medicine for use at the Homerton University Hospital Hospital only 2.5 Hypertension and heart failure->2.5.1 Vasodilator Tracleer® prescribing antihypertensive drugs->BOSENTAN Foundation Trust as the trust does not provide this specialist service. Specialist 2.5 Hypertension and heart failure->2.5.1 Vasodilator IVhydralazineshould only be prescribed in secondary care by or under the explicit direction of a HYDRALAZINE HYDROCHLORIDE knowledge drugs antihypertensive drugs specialist.

2.5 Hypertension and heart failure->2.5.1 Vasodilator Specialist Hydralazine antihypertensive drugs->HYDRALAZINE knowledge drugs HYDROCHLORIDE

2.5 Hypertension and heart failure->2.5.1 Vasodilator Specialist IVhydralazineshould only be prescribed in secondary care by or under the explicit direction of a Apresoline® antihypertensive drugs->HYDRALAZINE knowledge drugs specialist. HYDROCHLORIDE

2.5 Hypertension and heart failure->2.5.1 Vasodilator Hydralazine hydrochloride Not approved for antihypertensive drugs->HYDRALAZINE formulations [unlicensed] prescribing HYDROCHLORIDE

Hospital only 2.5 Hypertension and heart failure->2.5.1 Vasodilator ILOPROST prescribing antihypertensive drugs

Hospital only 2.5 Hypertension and heart failure->2.5.1 Vasodilator Ventavis® prescribing antihypertensive drugs->ILOPROST

Hospital only 2.5 Hypertension and heart failure->2.5.1 Vasodilator MACITENTAN prescribing antihypertensive drugs

Hospital only 2.5 Hypertension and heart failure->2.5.1 Vasodilator Opsumit® prescribing antihypertensive drugs->MACITENTAN

Specialist 2.5 Hypertension and heart failure->2.5.1 Vasodilator MINOXIDIL knowledge drugs antihypertensive drugs

Specialist 2.5 Hypertension and heart failure->2.5.1 Vasodilator Loniten® knowledge drugs antihypertensive drugs->MINOXIDIL

Not approved for 2.5 Hypertension and heart failure->2.5.1 Vasodilator Minoxidil formulations [unlicensed] prescribing antihypertensive drugs->MINOXIDIL

Hospital only 2.5 Hypertension and heart failure->2.5.1 Vasodilator RIOCIGUAT prescribing antihypertensive drugs

Hospital only 2.5 Hypertension and heart failure->2.5.1 Vasodilator Adempas® prescribing antihypertensive drugs->RIOCIGUAT

Hospital only 2.5 Hypertension and heart failure->2.5.1 Vasodilator For pulmonary hypertension sildenafilshould only be prescribed in secondary care by or under the SILDENAFIL prescribing antihypertensive drugs explicit direction of a specialist.

Hospital only 2.5 Hypertension and heart failure->2.5.1 Vasodilator Revatio® prescribing antihypertensive drugs->SILDENAFIL Not approved for 2.5 Hypertension and heart failure->2.5.1 Vasodilator Sildenafil formulations [unlicensed] prescribing antihypertensive drugs->SILDENAFIL

Hospital only 2.5 Hypertension and heart failure->2.5.1 Vasodilator SODIUM NITROPRUSSIDE prescribing antihypertensive drugs

Hospital only 2.5 Hypertension and heart failure->2.5.1 Vasodilator Sodium Nitroprusside prescribing antihypertensive drugs->SODIUM NITROPRUSSIDE

Hospital only 2.5 Hypertension and heart failure->2.5.1 Vasodilator TADALAFIL prescribing antihypertensive drugs

Hospital only 2.5 Hypertension and heart failure->2.5.1 Vasodilator Adcirca® prescribing antihypertensive drugs->TADALAFIL

Specialist 2.5 Hypertension and heart failure->2.5.2 Centrally Clonidine for the management of ADHD should only be prescribed in secondary care by or under CLONIDINE HYDROCHLORIDE knowledge drugs acting antihypertensive drugs the explicit direction of a specialist.

2.5 Hypertension and heart failure->2.5.2 Centrally Specialist Clonidine for the management of ADHD should only be prescribed in secondary care by or under Catapres® acting antihypertensive drugs->CLONIDINE knowledge drugs the explicit direction of a specialist. HYDROCHLORIDE

2.5 Hypertension and heart failure->2.5.2 Centrally Specialist Clonidine for the management of ADHD should only be prescribed in secondary care by or under Dixarit® acting antihypertensive drugs->CLONIDINE knowledge drugs the explicit direction of a specialist. HYDROCHLORIDE

2.5 Hypertension and heart failure->2.5.2 Centrally Clonidine hydrochloride Not approved for acting antihypertensive drugs->CLONIDINE formulations [unlicensed] prescribing HYDROCHLORIDE

Specialist 2.5 Hypertension and heart failure->2.5.2 Centrally METHYLDOPA knowledge drugs acting antihypertensive drugs

Specialist 2.5 Hypertension and heart failure->2.5.2 Centrally Methyldopa knowledge drugs acting antihypertensive drugs->METHYLDOPA

Specialist 2.5 Hypertension and heart failure->2.5.2 Centrally Aldomet® knowledge drugs acting antihypertensive drugs->METHYLDOPA

Methyldopa formulations Not approved for 2.5 Hypertension and heart failure->2.5.2 Centrally [unlicensed] prescribing acting antihypertensive drugs->METHYLDOPA

Specialist 2.5 Hypertension and heart failure->2.5.2 Centrally MOXONIDINE knowledge drugs acting antihypertensive drugs

Specialist 2.5 Hypertension and heart failure->2.5.2 Centrally Moxonidine knowledge drugs acting antihypertensive drugs->MOXONIDINE Specialist 2.5 Hypertension and heart failure->2.5.2 Centrally Physiotens® knowledge drugs acting antihypertensive drugs->MOXONIDINE

Not approved for Adrenergic neurone blocking drugs 2.5 Hypertension and heart failure prescribing

Not approved for 2.5 Hypertension and heart failure->2.5.3 Adrenergic GUANETHIDINE MONOSULFATE prescribing neurone blocking drugs

2.5 Hypertension and heart failure->2.5.3 Adrenergic Guanethidine Monosulfate None neurone blocking drugs->GUANETHIDINE MONOSULFATE

2.5 Hypertension and heart failure->2.5.4 DOXAZOSIN None Alpha-adrenoceptor blocking drugs

Joint formulary 2.5 Hypertension and heart failure->2.5.4 Doxazosin choice Alpha-adrenoceptor blocking drugs->DOXAZOSIN

Joint formulary 2.5 Hypertension and heart failure->2.5.4 Cardura® choice Alpha-adrenoceptor blocking drugs->DOXAZOSIN

Specialist 2.5 Hypertension and heart failure->2.5.4 Modified-release knowledge drugs Alpha-adrenoceptor blocking drugs->DOXAZOSIN

2.5 Hypertension and heart failure->2.5.4 Specialist Doxazosin Alpha-adrenoceptor blocking knowledge drugs drugs->DOXAZOSIN->Modified-release

2.5 Hypertension and heart failure->2.5.4 Specialist Cardura® XL Alpha-adrenoceptor blocking knowledge drugs drugs->DOXAZOSIN->Modified-release

Doxazosin formulations Not approved for 2.5 Hypertension and heart failure->2.5.4 [unlicensed] prescribing Alpha-adrenoceptor blocking drugs->DOXAZOSIN

Not approved for 2.5 Hypertension and heart failure->2.5.4 INDORAMIN prescribing Alpha-adrenoceptor blocking drugs

Not approved for 2.5 Hypertension and heart failure->2.5.4 Indoramin prescribing Alpha-adrenoceptor blocking drugs->INDORAMIN

Not approved for 2.5 Hypertension and heart failure->2.5.4 Doralese® prescribing Alpha-adrenoceptor blocking drugs->INDORAMIN

Not approved for 2.5 Hypertension and heart failure->2.5.4 PRAZOSIN prescribing Alpha-adrenoceptor blocking drugs

Not approved for 2.5 Hypertension and heart failure->2.5.4 Prazosin prescribing Alpha-adrenoceptor blocking drugs->PRAZOSIN Not approved for 2.5 Hypertension and heart failure->2.5.4 Hypovase® prescribing Alpha-adrenoceptor blocking drugs->PRAZOSIN

Not approved for 2.5 Hypertension and heart failure->2.5.4 TERAZOSIN prescribing Alpha-adrenoceptor blocking drugs

Not approved for 2.5 Hypertension and heart failure->2.5.4 Terazosin prescribing Alpha-adrenoceptor blocking drugs->TERAZOSIN

Not approved for 2.5 Hypertension and heart failure->2.5.4 Hytrin® prescribing Alpha-adrenoceptor blocking drugs->TERAZOSIN

2.5 Hypertension and heart failure->2.5.4 PHENOXYBENZAMINE Not approved for Alpha-adrenoceptor blocking HYDROCHLORIDE prescribing drugs->Phaeochromocytoma

2.5 Hypertension and heart failure->2.5.4 Not approved for Alpha-adrenoceptor blocking Phenoxybenzamine prescribing drugs->Phaeochromocytoma->PHENOXYBENZAMINE HYDROCHLORIDE

2.5 Hypertension and heart failure->2.5.4 Hospital only PHENTOLAMINE MESILATE Alpha-adrenoceptor blocking prescribing drugs->Phaeochromocytoma

2.5 Hypertension and heart failure->2.5.4 Hospital only Alpha-adrenoceptor blocking Phentolamine prescribing drugs->Phaeochromocytoma->PHENTOLAMINE MESILATE

2.5 Hypertension and heart failure->2.5.5 Drugs Joint formulary CAPTOPRIL affecting the renin-angiotensin system->2.5.5.1 choice Angiotensin-converting enzyme inhibitors

2.5 Hypertension and heart failure->2.5.5 Drugs Joint formulary Captopril affecting the renin-angiotensin system->2.5.5.1 choice Angiotensin-converting enzyme inhibitors->CAPTOPRIL

2.5 Hypertension and heart failure->2.5.5 Drugs Joint formulary Capoten® affecting the renin-angiotensin system->2.5.5.1 choice Angiotensin-converting enzyme inhibitors->CAPTOPRIL

2.5 Hypertension and heart failure->2.5.5 Drugs Joint formulary Noyada® affecting the renin-angiotensin system->2.5.5.1 choice Angiotensin-converting enzyme inhibitors->CAPTOPRIL 2.5 Hypertension and heart failure->2.5.5 Drugs Not approved for With diuretic affecting the renin-angiotensin system->2.5.5.1 prescribing Angiotensin-converting enzyme inhibitors->CAPTOPRIL

2.5 Hypertension and heart failure->2.5.5 Drugs Not approved for affecting the renin-angiotensin system->2.5.5.1 Co-zidocapt prescribing Angiotensin-converting enzyme inhibitors->CAPTOPRIL->With diuretic

2.5 Hypertension and heart failure->2.5.5 Drugs Not approved for affecting the renin-angiotensin system->2.5.5.1 Capozide® prescribing Angiotensin-converting enzyme inhibitors->CAPTOPRIL->With diuretic

2.5 Hypertension and heart failure->2.5.5 Drugs Not approved for Captopril formulations [unlicensed] affecting the renin-angiotensin system->2.5.5.1 prescribing Angiotensin-converting enzyme inhibitors->CAPTOPRIL

2.5 Hypertension and heart failure->2.5.5 Drugs Joint formulary ENALAPRIL MALEATE affecting the renin-angiotensin system->2.5.5.1 choice Angiotensin-converting enzyme inhibitors

2.5 Hypertension and heart failure->2.5.5 Drugs Joint formulary affecting the renin-angiotensin system->2.5.5.1 Enalapril Maleate choice Angiotensin-converting enzyme inhibitors->ENALAPRIL MALEATE

2.5 Hypertension and heart failure->2.5.5 Drugs Not approved for affecting the renin-angiotensin system->2.5.5.1 Innovace® Prescribe generically prescribing Angiotensin-converting enzyme inhibitors->ENALAPRIL MALEATE

2.5 Hypertension and heart failure->2.5.5 Drugs Not approved for affecting the renin-angiotensin system->2.5.5.1 With diuretic prescribing Angiotensin-converting enzyme inhibitors->ENALAPRIL MALEATE

2.5 Hypertension and heart failure->2.5.5 Drugs Not approved for affecting the renin-angiotensin system->2.5.5.1 Innozide® prescribing Angiotensin-converting enzyme inhibitors->ENALAPRIL MALEATE->With diuretic

2.5 Hypertension and heart failure->2.5.5 Drugs Not approved for FOSINOPRIL SODIUM affecting the renin-angiotensin system->2.5.5.1 prescribing Angiotensin-converting enzyme inhibitors 2.5 Hypertension and heart failure->2.5.5 Drugs Not approved for affecting the renin-angiotensin system->2.5.5.1 Fosinopril sodium prescribing Angiotensin-converting enzyme inhibitors->FOSINOPRIL SODIUM

2.5 Hypertension and heart failure->2.5.5 Drugs Not approved for IMIDAPRIL HYDROCHLORIDE affecting the renin-angiotensin system->2.5.5.1 prescribing Angiotensin-converting enzyme inhibitors

2.5 Hypertension and heart failure->2.5.5 Drugs Not approved for affecting the renin-angiotensin system->2.5.5.1 Tanatril® prescribing Angiotensin-converting enzyme inhibitors->IMIDAPRIL HYDROCHLORIDE

2.5 Hypertension and heart failure->2.5.5 Drugs Joint formulary LISINOPRIL affecting the renin-angiotensin system->2.5.5.1 choice Angiotensin-converting enzyme inhibitors

2.5 Hypertension and heart failure->2.5.5 Drugs Joint formulary Lisinopril affecting the renin-angiotensin system->2.5.5.1 choice Angiotensin-converting enzyme inhibitors->LISINOPRIL

2.5 Hypertension and heart failure->2.5.5 Drugs Joint formulary Zestril® affecting the renin-angiotensin system->2.5.5.1 choice Angiotensin-converting enzyme inhibitors->LISINOPRIL

2.5 Hypertension and heart failure->2.5.5 Drugs Not approved for With diuretic affecting the renin-angiotensin system->2.5.5.1 prescribing Angiotensin-converting enzyme inhibitors->LISINOPRIL

2.5 Hypertension and heart failure->2.5.5 Drugs Not approved for affecting the renin-angiotensin system->2.5.5.1 Carace Plus® prescribing Angiotensin-converting enzyme inhibitors->LISINOPRIL->With diuretic

2.5 Hypertension and heart failure->2.5.5 Drugs Not approved for affecting the renin-angiotensin system->2.5.5.1 Zestoretic® prescribing Angiotensin-converting enzyme inhibitors->LISINOPRIL->With diuretic

2.5 Hypertension and heart failure->2.5.5 Drugs Not approved for Lisinopril formulations [unlicensed] affecting the renin-angiotensin system->2.5.5.1 prescribing Angiotensin-converting enzyme inhibitors->LISINOPRIL

2.5 Hypertension and heart failure->2.5.5 Drugs Not approved for MOEXIPRIL HYDROCHLORIDE affecting the renin-angiotensin system->2.5.5.1 prescribing Angiotensin-converting enzyme inhibitors 2.5 Hypertension and heart failure->2.5.5 Drugs Not approved for affecting the renin-angiotensin system->2.5.5.1 Perdix® prescribing Angiotensin-converting enzyme inhibitors->MOEXIPRIL HYDROCHLORIDE

2.5 Hypertension and heart failure->2.5.5 Drugs Joint formulary PERINDOPRIL ERBUMINE affecting the renin-angiotensin system->2.5.5.1 choice Angiotensin-converting enzyme inhibitors

2.5 Hypertension and heart failure->2.5.5 Drugs Joint formulary affecting the renin-angiotensin system->2.5.5.1 Perindopril choice Angiotensin-converting enzyme inhibitors->PERINDOPRIL ERBUMINE

2.5 Hypertension and heart failure->2.5.5 Drugs Not approved for PERINDOPRIL ARGININE affecting the renin-angiotensin system->2.5.5.1 prescribing Angiotensin-converting enzyme inhibitors

2.5 Hypertension and heart failure->2.5.5 Drugs Not approved for affecting the renin-angiotensin system->2.5.5.1 Coversyl® Arginine prescribing Angiotensin-converting enzyme inhibitors->PERINDOPRIL ARGININE

2.5 Hypertension and heart failure->2.5.5 Drugs Not approved for affecting the renin-angiotensin system->2.5.5.1 Perindopril arginine with diuretic prescribing Angiotensin-converting enzyme inhibitors->PERINDOPRIL ARGININE

2.5 Hypertension and heart failure->2.5.5 Drugs affecting the renin-angiotensin system->2.5.5.1 Not approved for Coversyl® Arginine Plus Angiotensin-converting enzyme prescribing inhibitors->PERINDOPRIL ARGININE->Perindopril arginine with diuretic

2.5 Hypertension and heart failure->2.5.5 Drugs Not approved for QUINAPRIL affecting the renin-angiotensin system->2.5.5.1 prescribing Angiotensin-converting enzyme inhibitors

2.5 Hypertension and heart failure->2.5.5 Drugs Not approved for Quinapril affecting the renin-angiotensin system->2.5.5.1 prescribing Angiotensin-converting enzyme inhibitors->QUINAPRIL

2.5 Hypertension and heart failure->2.5.5 Drugs Not approved for Accupro® affecting the renin-angiotensin system->2.5.5.1 prescribing Angiotensin-converting enzyme inhibitors->QUINAPRIL 2.5 Hypertension and heart failure->2.5.5 Drugs Not approved for With diuretic affecting the renin-angiotensin system->2.5.5.1 prescribing Angiotensin-converting enzyme inhibitors->QUINAPRIL

2.5 Hypertension and heart failure->2.5.5 Drugs Not approved for affecting the renin-angiotensin system->2.5.5.1 Accuretic® prescribing Angiotensin-converting enzyme inhibitors->QUINAPRIL->With diuretic

2.5 Hypertension and heart failure->2.5.5 Drugs Joint formulary RAMIPRIL affecting the renin-angiotensin system->2.5.5.1 choice Angiotensin-converting enzyme inhibitors

2.5 Hypertension and heart failure->2.5.5 Drugs Joint formulary Ramipril affecting the renin-angiotensin system->2.5.5.1 choice Angiotensin-converting enzyme inhibitors->RAMIPRIL

2.5 Hypertension and heart failure->2.5.5 Drugs Joint formulary Tritace® affecting the renin-angiotensin system->2.5.5.1 choice Angiotensin-converting enzyme inhibitors->RAMIPRIL

2.5 Hypertension and heart failure->2.5.5 Drugs Not approved for RAMIPRIL WITH FELODIPINE affecting the renin-angiotensin system->2.5.5.1 prescribing Angiotensin-converting enzyme inhibitors

2.5 Hypertension and heart failure->2.5.5 Drugs Not approved for affecting the renin-angiotensin system->2.5.5.1 Triapin® prescribing Angiotensin-converting enzyme inhibitors->RAMIPRIL WITH FELODIPINE

2.5 Hypertension and heart failure->2.5.5 Drugs Not approved for TRANDOLAPRIL affecting the renin-angiotensin system->2.5.5.1 prescribing Angiotensin-converting enzyme inhibitors

2.5 Hypertension and heart failure->2.5.5 Drugs Not approved for affecting the renin-angiotensin system->2.5.5.1 Trandolapril prescribing Angiotensin-converting enzyme inhibitors->TRANDOLAPRIL

2.5 Hypertension and heart failure->2.5.5 Drugs Not approved for AZILSARTAN MEDOXOMIL affecting the renin-angiotensin system->2.5.5.2 prescribing Angiotensin-II receptor antagonists

2.5 Hypertension and heart failure->2.5.5 Drugs Not approved for affecting the renin-angiotensin system->2.5.5.2 Edarbi® prescribing Angiotensin-II receptor antagonists->AZILSARTAN MEDOXOMIL 2.5 Hypertension and heart failure->2.5.5 Drugs Joint formulary CANDESARTAN CILEXETIL affecting the renin-angiotensin system->2.5.5.2 choice Angiotensin-II receptor antagonists

2.5 Hypertension and heart failure->2.5.5 Drugs affecting the renin-angiotensin system->2.5.5.2 Candesartan Cilexetil None Angiotensin-II receptor antagonists->CANDESARTAN CILEXETIL

2.5 Hypertension and heart failure->2.5.5 Drugs Not approved for affecting the renin-angiotensin system->2.5.5.2 Amias® Prescribe generically. prescribing Angiotensin-II receptor antagonists->CANDESARTAN CILEXETIL

2.5 Hypertension and heart failure->2.5.5 Drugs Not approved for EPROSARTAN affecting the renin-angiotensin system->2.5.5.2 prescribing Angiotensin-II receptor antagonists

2.5 Hypertension and heart failure->2.5.5 Drugs Not approved for Teveten® affecting the renin-angiotensin system->2.5.5.2 prescribing Angiotensin-II receptor antagonists->EPROSARTAN

2.5 Hypertension and heart failure->2.5.5 Drugs Specialist IRBESARTAN affecting the renin-angiotensin system->2.5.5.2 knowledge drugs Angiotensin-II receptor antagonists

2.5 Hypertension and heart failure->2.5.5 Drugs Specialist Irbesartan affecting the renin-angiotensin system->2.5.5.2 knowledge drugs Angiotensin-II receptor antagonists->IRBESARTAN

2.5 Hypertension and heart failure->2.5.5 Drugs Specialist Aprovel® affecting the renin-angiotensin system->2.5.5.2 knowledge drugs Angiotensin-II receptor antagonists->IRBESARTAN

2.5 Hypertension and heart failure->2.5.5 Drugs Not approved for With diuretic affecting the renin-angiotensin system->2.5.5.2 prescribing Angiotensin-II receptor antagonists->IRBESARTAN

2.5 Hypertension and heart failure->2.5.5 Drugs Not approved for affecting the renin-angiotensin system->2.5.5.2 Irbesartan with hydrochlorothiazide prescribing Angiotensin-II receptor antagonists->IRBESARTAN->With diuretic

2.5 Hypertension and heart failure->2.5.5 Drugs Not approved for affecting the renin-angiotensin system->2.5.5.2 CoAprovel® prescribing Angiotensin-II receptor antagonists->IRBESARTAN->With diuretic 2.5 Hypertension and heart failure->2.5.5 Drugs Joint formulary LOSARTAN POTASSIUM affecting the renin-angiotensin system->2.5.5.2 choice Angiotensin-II receptor antagonists

2.5 Hypertension and heart failure->2.5.5 Drugs Joint formulary affecting the renin-angiotensin system->2.5.5.2 Losartan Potassium choice Angiotensin-II receptor antagonists->LOSARTAN POTASSIUM

2.5 Hypertension and heart failure->2.5.5 Drugs Not approved for affecting the renin-angiotensin system->2.5.5.2 Cozaar® prescribing Angiotensin-II receptor antagonists->LOSARTAN POTASSIUM

2.5 Hypertension and heart failure->2.5.5 Drugs Not approved for affecting the renin-angiotensin system->2.5.5.2 With diuretic prescribing Angiotensin-II receptor antagonists->LOSARTAN POTASSIUM

2.5 Hypertension and heart failure->2.5.5 Drugs Losartan potassium with Not approved for affecting the renin-angiotensin system->2.5.5.2 hydrochlorothiazide prescribing Angiotensin-II receptor antagonists->LOSARTAN POTASSIUM->With diuretic

2.5 Hypertension and heart failure->2.5.5 Drugs Not approved for affecting the renin-angiotensin system->2.5.5.2 Cozaar-Comp® prescribing Angiotensin-II receptor antagonists->LOSARTAN POTASSIUM->With diuretic

2.5 Hypertension and heart failure->2.5.5 Drugs Not approved for OLMESARTAN MEDOXOMIL affecting the renin-angiotensin system->2.5.5.2 prescribing Angiotensin-II receptor antagonists

2.5 Hypertension and heart failure->2.5.5 Drugs Not approved for affecting the renin-angiotensin system->2.5.5.2 Olmetec® prescribing Angiotensin-II receptor antagonists->OLMESARTAN MEDOXOMIL

2.5 Hypertension and heart failure->2.5.5 Drugs Not approved for affecting the renin-angiotensin system->2.5.5.2 With calcium-channel blocker prescribing Angiotensin-II receptor antagonists->OLMESARTAN MEDOXOMIL

2.5 Hypertension and heart failure->2.5.5 Drugs Not approved for affecting the renin-angiotensin system->2.5.5.2 Sevikar® prescribing Angiotensin-II receptor antagonists->OLMESARTAN MEDOXOMIL->With calcium-channel blocker 2.5 Hypertension and heart failure->2.5.5 Drugs With calcium-channel blocker and Not approved for affecting the renin-angiotensin system->2.5.5.2 diuretic prescribing Angiotensin-II receptor antagonists->OLMESARTAN MEDOXOMIL

2.5 Hypertension and heart failure->2.5.5 Drugs Not approved for affecting the renin-angiotensin system->2.5.5.2 Sevikar HCT® prescribing Angiotensin-II receptor antagonists->OLMESARTAN MEDOXOMIL->With calcium-channel blocker and diuretic

2.5 Hypertension and heart failure->2.5.5 Drugs Not approved for affecting the renin-angiotensin system->2.5.5.2 With diuretic prescribing Angiotensin-II receptor antagonists->OLMESARTAN MEDOXOMIL

2.5 Hypertension and heart failure->2.5.5 Drugs Not approved for affecting the renin-angiotensin system->2.5.5.2 Olmetec Plus® prescribing Angiotensin-II receptor antagonists->OLMESARTAN MEDOXOMIL->With diuretic

2.5 Hypertension and heart failure->2.5.5 Drugs Not approved for TELMISARTAN affecting the renin-angiotensin system->2.5.5.2 prescribing Angiotensin-II receptor antagonists

2.5 Hypertension and heart failure->2.5.5 Drugs Not approved for Micardis® affecting the renin-angiotensin system->2.5.5.2 prescribing Angiotensin-II receptor antagonists->TELMISARTAN

2.5 Hypertension and heart failure->2.5.5 Drugs Not approved for With diuretic affecting the renin-angiotensin system->2.5.5.2 prescribing Angiotensin-II receptor antagonists->TELMISARTAN

2.5 Hypertension and heart failure->2.5.5 Drugs Not approved for affecting the renin-angiotensin system->2.5.5.2 Micardis Plus® prescribing Angiotensin-II receptor antagonists->TELMISARTAN->With diuretic

2.5 Hypertension and heart failure->2.5.5 Drugs VALSARTAN None affecting the renin-angiotensin system->2.5.5.2 Angiotensin-II receptor antagonists

2.5 Hypertension and heart failure->2.5.5 Drugs Joint formulary Valsartan affecting the renin-angiotensin system->2.5.5.2 choice Angiotensin-II receptor antagonists->VALSARTAN

2.5 Hypertension and heart failure->2.5.5 Drugs Joint formulary Diovan® affecting the renin-angiotensin system->2.5.5.2 choice Angiotensin-II receptor antagonists->VALSARTAN 2.5 Hypertension and heart failure->2.5.5 Drugs Not approved for With diuretic affecting the renin-angiotensin system->2.5.5.2 prescribing Angiotensin-II receptor antagonists->VALSARTAN

2.5 Hypertension and heart failure->2.5.5 Drugs Not approved for affecting the renin-angiotensin system->2.5.5.2 Valsartan with hydrochlorothiazide prescribing Angiotensin-II receptor antagonists->VALSARTAN->With diuretic

2.5 Hypertension and heart failure->2.5.5 Drugs Not approved for affecting the renin-angiotensin system->2.5.5.2 Co-Diovan® prescribing Angiotensin-II receptor antagonists->VALSARTAN->With diuretic

2.5 Hypertension and heart failure->2.5.5 Drugs Specialist With sacubitril affecting the renin-angiotensin system->2.5.5.2 knowledge drugs Angiotensin-II receptor antagonists->VALSARTAN

2.5 Hypertension and heart failure->2.5.5 Drugs Specialist affecting the renin-angiotensin system->2.5.5.2 Entresto® knowledge drugs Angiotensin-II receptor antagonists->VALSARTAN->With sacubitril

2.5 Hypertension and heart failure->2.5.5 Drugs Not approved for With amlodipine affecting the renin-angiotensin system->2.5.5.2 prescribing Angiotensin-II receptor antagonists->VALSARTAN

Not approved for 2.5 Hypertension and heart failure->2.5.5 Drugs Renin inhibitors prescribing affecting the renin-angiotensin system

2.5 Hypertension and heart failure->2.5.5 Drugs Not approved for ALISKIREN affecting the renin-angiotensin system->2.5.5.3 Renin prescribing inhibitors

2.5 Hypertension and heart failure->2.5.5 Drugs Not approved for Rasilez® affecting the renin-angiotensin system->2.5.5.3 Renin prescribing inhibitors->ALISKIREN

Joint formulary 2.6 Nitrates, calcium-channel blockers, and other GLYCERYL TRINITRATE choice antianginal drugs->2.6.1 Nitrates

2.6 Nitrates, calcium-channel blockers, and other Joint formulary Glyceryl Trinitrate antianginal drugs->2.6.1 Nitrates->GLYCERYL choice TRINITRATE->Short-acting tablets and sprays

2.6 Nitrates, calcium-channel blockers, and other Joint formulary Coro-Nitro Pump Spray® antianginal drugs->2.6.1 Nitrates->GLYCERYL choice TRINITRATE->Short-acting tablets and sprays 2.6 Nitrates, calcium-channel blockers, and other Glytrin Spray® None antianginal drugs->2.6.1 Nitrates->GLYCERYL TRINITRATE->Short-acting tablets and sprays

2.6 Nitrates, calcium-channel blockers, and other Joint formulary GTN 300 mcg antianginal drugs->2.6.1 Nitrates->GLYCERYL choice TRINITRATE->Short-acting tablets and sprays

2.6 Nitrates, calcium-channel blockers, and other Joint formulary Nitrolingual Pumpspray® antianginal drugs->2.6.1 Nitrates->GLYCERYL choice TRINITRATE->Short-acting tablets and sprays

2.6 Nitrates, calcium-channel blockers, and other Joint formulary Nitromin® antianginal drugs->2.6.1 Nitrates->GLYCERYL choice TRINITRATE->Short-acting tablets and sprays

2.6 Nitrates, calcium-channel blockers, and other Hospital only Parenteral preparations antianginal drugs->2.6.1 Nitrates->GLYCERYL prescribing TRINITRATE

2.6 Nitrates, calcium-channel blockers, and other Hospital only Glyceryl Trinitrate antianginal drugs->2.6.1 Nitrates->GLYCERYL prescribing TRINITRATE->Parenteral preparations

2.6 Nitrates, calcium-channel blockers, and other Hospital only Nitrocine® antianginal drugs->2.6.1 Nitrates->GLYCERYL prescribing TRINITRATE->Parenteral preparations

2.6 Nitrates, calcium-channel blockers, and other Hospital only Nitronal® antianginal drugs->2.6.1 Nitrates->GLYCERYL prescribing TRINITRATE->Parenteral preparations

2.6 Nitrates, calcium-channel blockers, and other Joint formulary Deponit® antianginal drugs->2.6.1 Nitrates->GLYCERYL choice TRINITRATE->Transdermal preparations

2.6 Nitrates, calcium-channel blockers, and other Joint formulary Minitran® antianginal drugs->2.6.1 Nitrates->GLYCERYL choice TRINITRATE->Transdermal preparations

2.6 Nitrates, calcium-channel blockers, and other Joint formulary Nitro-Dur® antianginal drugs->2.6.1 Nitrates->GLYCERYL choice TRINITRATE->Transdermal preparations

2.6 Nitrates, calcium-channel blockers, and other Not approved for Percutol® antianginal drugs->2.6.1 Nitrates->GLYCERYL prescribing TRINITRATE->Transdermal preparations 2.6 Nitrates, calcium-channel blockers, and other Joint formulary Transiderm-Nitro® antianginal drugs->2.6.1 Nitrates->GLYCERYL choice TRINITRATE->Transdermal preparations

Not approved for 2.6 Nitrates, calcium-channel blockers, and other ISOSORBIDE DINITRATE prescribing antianginal drugs->2.6.1 Nitrates

2.6 Nitrates, calcium-channel blockers, and other Not approved for Short-acting tablets and sprays antianginal drugs->2.6.1 Nitrates->ISOSORBIDE prescribing DINITRATE

2.6 Nitrates, calcium-channel blockers, and other Not approved for Isosorbide Dinitrate antianginal drugs->2.6.1 Nitrates->ISOSORBIDE prescribing DINITRATE->Short-acting tablets and sprays

2.6 Nitrates, calcium-channel blockers, and other Not approved for Angitak® antianginal drugs->2.6.1 Nitrates->ISOSORBIDE prescribing DINITRATE->Short-acting tablets and sprays

2.6 Nitrates, calcium-channel blockers, and other Not approved for Modified-release preparations antianginal drugs->2.6.1 Nitrates->ISOSORBIDE prescribing DINITRATE

2.6 Nitrates, calcium-channel blockers, and other Not approved for Isoket Retard® antianginal drugs->2.6.1 Nitrates->ISOSORBIDE prescribing DINITRATE->Modified-release preparations

2.6 Nitrates, calcium-channel blockers, and other Not approved for Parenteral preparations antianginal drugs->2.6.1 Nitrates->ISOSORBIDE prescribing DINITRATE

2.6 Nitrates, calcium-channel blockers, and other Not approved for Isoket® antianginal drugs->2.6.1 Nitrates->ISOSORBIDE prescribing DINITRATE->Parenteral preparations

Joint formulary 2.6 Nitrates, calcium-channel blockers, and other ISOSORBIDE MONONITRATE choice antianginal drugs->2.6.1 Nitrates

2.6 Nitrates, calcium-channel blockers, and other Joint formulary Isosorbide Mononitrate antianginal drugs->2.6.1 Nitrates->ISOSORBIDE choice MONONITRATE

2.6 Nitrates, calcium-channel blockers, and other Joint formulary Ismo® antianginal drugs->2.6.1 Nitrates->ISOSORBIDE choice MONONITRATE 2.6 Nitrates, calcium-channel blockers, and other Joint formulary Modified release antianginal drugs->2.6.1 Nitrates->ISOSORBIDE choice MONONITRATE

2.6 Nitrates, calcium-channel blockers, and other Joint formulary Chemydur® 60XL antianginal drugs->2.6.1 Nitrates->ISOSORBIDE choice MONONITRATE->Modified release

2.6 Nitrates, calcium-channel blockers, and other Joint formulary Elantan LA® antianginal drugs->2.6.1 Nitrates->ISOSORBIDE choice MONONITRATE->Modified release

2.6 Nitrates, calcium-channel blockers, and other Joint formulary Imdur® antianginal drugs->2.6.1 Nitrates->ISOSORBIDE choice MONONITRATE->Modified release

2.6 Nitrates, calcium-channel blockers, and other Joint formulary Isib 60XL® antianginal drugs->2.6.1 Nitrates->ISOSORBIDE choice MONONITRATE->Modified release

2.6 Nitrates, calcium-channel blockers, and other Joint formulary Ismo Retard® antianginal drugs->2.6.1 Nitrates->ISOSORBIDE choice MONONITRATE->Modified release

2.6 Nitrates, calcium-channel blockers, and other Joint formulary Isodur® antianginal drugs->2.6.1 Nitrates->ISOSORBIDE choice MONONITRATE->Modified release

2.6 Nitrates, calcium-channel blockers, and other Joint formulary Isotard® antianginal drugs->2.6.1 Nitrates->ISOSORBIDE choice MONONITRATE->Modified release

2.6 Nitrates, calcium-channel blockers, and other Joint formulary Modisal XL® antianginal drugs->2.6.1 Nitrates->ISOSORBIDE choice MONONITRATE->Modified release

2.6 Nitrates, calcium-channel blockers, and other Joint formulary Monomax® antianginal drugs->2.6.1 Nitrates->ISOSORBIDE choice MONONITRATE->Modified release

2.6 Nitrates, calcium-channel blockers, and other Joint formulary Monomil XL® antianginal drugs->2.6.1 Nitrates->ISOSORBIDE choice MONONITRATE->Modified release

2.6 Nitrates, calcium-channel blockers, and other Joint formulary Monosorb XL 60® antianginal drugs->2.6.1 Nitrates->ISOSORBIDE choice MONONITRATE->Modified release 2.6 Nitrates, calcium-channel blockers, and other Joint formulary Zemon® antianginal drugs->2.6.1 Nitrates->ISOSORBIDE choice MONONITRATE->Modified release

Joint formulary 2.6 Nitrates, calcium-channel blockers, and other AMLODIPINE choice antianginal drugs->2.6.2 Calcium-channel blockers

2.6 Nitrates, calcium-channel blockers, and other Joint formulary Amlodipine antianginal drugs->2.6.2 Calcium-channel choice blockers->AMLODIPINE

2.6 Nitrates, calcium-channel blockers, and other Not approved for Istin® antianginal drugs->2.6.2 Calcium-channel prescribing blockers->AMLODIPINE

2.6 Nitrates, calcium-channel blockers, and other Not approved for With valsartan antianginal drugs->2.6.2 Calcium-channel prescribing blockers->AMLODIPINE

2.6 Nitrates, calcium-channel blockers, and other Not approved for Exforge® antianginal drugs->2.6.2 Calcium-channel prescribing blockers->AMLODIPINE->With valsartan

2.6 Nitrates, calcium-channel blockers, and other Amlodipine formulations Not approved for antianginal drugs->2.6.2 Calcium-channel [unlicensed] prescribing blockers->AMLODIPINE

2.6 Nitrates, calcium-channel blockers, and other CLEVIDIPINE None antianginal drugs->2.6.2 Calcium-channel blockers

2.6 Nitrates, calcium-channel blockers, and other Cleviprex® None antianginal drugs->2.6.2 Calcium-channel blockers->CLEVIDIPINE

Joint formulary 2.6 Nitrates, calcium-channel blockers, and other DILTIAZEM HYDROCHLORIDE choice antianginal drugs->2.6.2 Calcium-channel blockers

2.6 Nitrates, calcium-channel blockers, and other Joint formulary Standard formulations antianginal drugs->2.6.2 Calcium-channel choice blockers->DILTIAZEM HYDROCHLORIDE

2.6 Nitrates, calcium-channel blockers, and other Joint formulary antianginal drugs->2.6.2 Calcium-channel Diltiazem choice blockers->DILTIAZEM HYDROCHLORIDE->Standard formulations 2.6 Nitrates, calcium-channel blockers, and other Joint formulary antianginal drugs->2.6.2 Calcium-channel Tildiem® choice blockers->DILTIAZEM HYDROCHLORIDE->Standard formulations

2.6 Nitrates, calcium-channel blockers, and other Joint formulary Longer-acting formulations antianginal drugs->2.6.2 Calcium-channel choice blockers->DILTIAZEM HYDROCHLORIDE

2.6 Nitrates, calcium-channel blockers, and other Joint formulary antianginal drugs->2.6.2 Calcium-channel Adizem-SR® choice blockers->DILTIAZEM HYDROCHLORIDE->Longer-acting formulations

2.6 Nitrates, calcium-channel blockers, and other Joint formulary antianginal drugs->2.6.2 Calcium-channel Adizem-XL® choice blockers->DILTIAZEM HYDROCHLORIDE->Longer-acting formulations

2.6 Nitrates, calcium-channel blockers, and other Joint formulary antianginal drugs->2.6.2 Calcium-channel Angitil SR® choice blockers->DILTIAZEM HYDROCHLORIDE->Longer-acting formulations

2.6 Nitrates, calcium-channel blockers, and other Joint formulary antianginal drugs->2.6.2 Calcium-channel Angitil XL® choice blockers->DILTIAZEM HYDROCHLORIDE->Longer-acting formulations

2.6 Nitrates, calcium-channel blockers, and other Joint formulary antianginal drugs->2.6.2 Calcium-channel Dilcardia SR® choice blockers->DILTIAZEM HYDROCHLORIDE->Longer-acting formulations

2.6 Nitrates, calcium-channel blockers, and other Joint formulary antianginal drugs->2.6.2 Calcium-channel Dilzem SR® choice blockers->DILTIAZEM HYDROCHLORIDE->Longer-acting formulations

2.6 Nitrates, calcium-channel blockers, and other Joint formulary antianginal drugs->2.6.2 Calcium-channel Dilzem XL® choice blockers->DILTIAZEM HYDROCHLORIDE->Longer-acting formulations

2.6 Nitrates, calcium-channel blockers, and other Joint formulary antianginal drugs->2.6.2 Calcium-channel Slozem® choice blockers->DILTIAZEM HYDROCHLORIDE->Longer-acting formulations 2.6 Nitrates, calcium-channel blockers, and other Joint formulary antianginal drugs->2.6.2 Calcium-channel Tildiem LA® choice blockers->DILTIAZEM HYDROCHLORIDE->Longer-acting formulations

2.6 Nitrates, calcium-channel blockers, and other Joint formulary antianginal drugs->2.6.2 Calcium-channel Tildiem Retard® choice blockers->DILTIAZEM HYDROCHLORIDE->Longer-acting formulations

2.6 Nitrates, calcium-channel blockers, and other Joint formulary antianginal drugs->2.6.2 Calcium-channel Viazem XL® choice blockers->DILTIAZEM HYDROCHLORIDE->Longer-acting formulations

2.6 Nitrates, calcium-channel blockers, and other Joint formulary antianginal drugs->2.6.2 Calcium-channel Zemtard® choice blockers->DILTIAZEM HYDROCHLORIDE->Longer-acting formulations

Not approved for 2.6 Nitrates, calcium-channel blockers, and other FELODIPINE prescribing antianginal drugs->2.6.2 Calcium-channel blockers

2.6 Nitrates, calcium-channel blockers, and other Not approved for Felodipine antianginal drugs->2.6.2 Calcium-channel prescribing blockers->FELODIPINE

2.6 Nitrates, calcium-channel blockers, and other Not approved for Plendil® antianginal drugs->2.6.2 Calcium-channel prescribing blockers->FELODIPINE

2.6 Nitrates, calcium-channel blockers, and other Not approved for With ramipril antianginal drugs->2.6.2 Calcium-channel prescribing blockers->FELODIPINE

Not approved for 2.6 Nitrates, calcium-channel blockers, and other ISRADIPINE prescribing antianginal drugs->2.6.2 Calcium-channel blockers

2.6 Nitrates, calcium-channel blockers, and other Not approved for Isradipine antianginal drugs->2.6.2 Calcium-channel prescribing blockers->ISRADIPINE

Not approved for 2.6 Nitrates, calcium-channel blockers, and other LACIDIPINE prescribing antianginal drugs->2.6.2 Calcium-channel blockers

2.6 Nitrates, calcium-channel blockers, and other Not approved for Motens® antianginal drugs->2.6.2 Calcium-channel prescribing blockers->LACIDIPINE Not approved for 2.6 Nitrates, calcium-channel blockers, and other LERCANIDIPINE HYDROCHLORIDE prescribing antianginal drugs->2.6.2 Calcium-channel blockers

2.6 Nitrates, calcium-channel blockers, and other Not approved for Lercanidipine Hydrochloride antianginal drugs->2.6.2 Calcium-channel prescribing blockers->LERCANIDIPINE HYDROCHLORIDE

2.6 Nitrates, calcium-channel blockers, and other Not approved for Zanidip® antianginal drugs->2.6.2 Calcium-channel prescribing blockers->LERCANIDIPINE HYDROCHLORIDE

Not approved for 2.6 Nitrates, calcium-channel blockers, and other NICARDIPINE HYDROCHLORIDE prescribing antianginal drugs->2.6.2 Calcium-channel blockers

2.6 Nitrates, calcium-channel blockers, and other Not approved for Nicardipine antianginal drugs->2.6.2 Calcium-channel prescribing blockers->NICARDIPINE HYDROCHLORIDE

2.6 Nitrates, calcium-channel blockers, and other Nicardipine None antianginal drugs->2.6.2 Calcium-channel blockers->NICARDIPINE HYDROCHLORIDE

2.6 Nitrates, calcium-channel blockers, and other Not approved for Cardene® antianginal drugs->2.6.2 Calcium-channel prescribing blockers->NICARDIPINE HYDROCHLORIDE

2.6 Nitrates, calcium-channel blockers, and other Not approved for Modified release antianginal drugs->2.6.2 Calcium-channel prescribing blockers->NICARDIPINE HYDROCHLORIDE

2.6 Nitrates, calcium-channel blockers, and other Not approved for antianginal drugs->2.6.2 Calcium-channel Cardene SR® prescribing blockers->NICARDIPINE HYDROCHLORIDE->Modified release

2.6 Nitrates, calcium-channel blockers, and other NIFEDIPINE None antianginal drugs->2.6.2 Calcium-channel blockers

2.6 Nitrates, calcium-channel blockers, and other Not approved for Nifedipine antianginal drugs->2.6.2 Calcium-channel prescribing blockers->NIFEDIPINE

2.6 Nitrates, calcium-channel blockers, and other Joint formulary Adalat® antianginal drugs->2.6.2 Calcium-channel choice blockers->NIFEDIPINE 2.6 Nitrates, calcium-channel blockers, and other Joint formulary Modified release antianginal drugs->2.6.2 Calcium-channel choice blockers->NIFEDIPINE

2.6 Nitrates, calcium-channel blockers, and other Joint formulary Adalat® LA antianginal drugs->2.6.2 Calcium-channel choice blockers->NIFEDIPINE->Modified release

2.6 Nitrates, calcium-channel blockers, and other Joint formulary Adalat® Retard antianginal drugs->2.6.2 Calcium-channel choice blockers->NIFEDIPINE->Modified release

2.6 Nitrates, calcium-channel blockers, and other Joint formulary Adipine® MR antianginal drugs->2.6.2 Calcium-channel choice blockers->NIFEDIPINE->Modified release

2.6 Nitrates, calcium-channel blockers, and other Joint formulary Adipine® XL antianginal drugs->2.6.2 Calcium-channel choice blockers->NIFEDIPINE->Modified release

2.6 Nitrates, calcium-channel blockers, and other Joint formulary Coracten SR® antianginal drugs->2.6.2 Calcium-channel choice blockers->NIFEDIPINE->Modified release

2.6 Nitrates, calcium-channel blockers, and other Joint formulary Coracten XL® antianginal drugs->2.6.2 Calcium-channel choice blockers->NIFEDIPINE->Modified release

2.6 Nitrates, calcium-channel blockers, and other Joint formulary Fortipine LA 40® antianginal drugs->2.6.2 Calcium-channel choice blockers->NIFEDIPINE->Modified release

2.6 Nitrates, calcium-channel blockers, and other Joint formulary Nifedipress® MR antianginal drugs->2.6.2 Calcium-channel choice blockers->NIFEDIPINE->Modified release

2.6 Nitrates, calcium-channel blockers, and other Joint formulary Tensipine MR® antianginal drugs->2.6.2 Calcium-channel choice blockers->NIFEDIPINE->Modified release

2.6 Nitrates, calcium-channel blockers, and other Joint formulary Valni XL® antianginal drugs->2.6.2 Calcium-channel choice blockers->NIFEDIPINE->Modified release

2.6 Nitrates, calcium-channel blockers, and other Not approved for With atenolol antianginal drugs->2.6.2 Calcium-channel prescribing blockers->NIFEDIPINE Hospital only 2.6 Nitrates, calcium-channel blockers, and other NIMODIPINE prescribing antianginal drugs->2.6.2 Calcium-channel blockers

2.6 Nitrates, calcium-channel blockers, and other Hospital only Nimotop® antianginal drugs->2.6.2 Calcium-channel prescribing blockers->NIMODIPINE Verapamil injectionshould only be prescribed in secondary care by or under the explicit direction of a specialist. Joint formulary 2.6 Nitrates, calcium-channel blockers, and other VERAPAMIL HYDROCHLORIDE choice antianginal drugs->2.6.2 Calcium-channel blockers Oral verapamil for cluster headaches should be prescribed under the explicit direction of a specialist only.

2.6 Nitrates, calcium-channel blockers, and other Joint formulary Oral verapamil for cluster headaches should be prescribed under the explicit direction of Verapamil antianginal drugs->2.6.2 Calcium-channel choice a specialist only. blockers->VERAPAMIL HYDROCHLORIDE Verapamil injectionshould only be prescribed in secondary care by or under the explicit 2.6 Nitrates, calcium-channel blockers, and other direction of a specialist. Joint formulary Cordilox® antianginal drugs->2.6.2 Calcium-channel choice blockers->VERAPAMIL HYDROCHLORIDE Oral verapamil for cluster headaches should be prescribed under the explicit direction of a specialist only.

2.6 Nitrates, calcium-channel blockers, and other Hospital only Securon® antianginal drugs->2.6.2 Calcium-channel prescribing blockers->VERAPAMIL HYDROCHLORIDE

2.6 Nitrates, calcium-channel blockers, and other Joint formulary Oral verapamil for cluster headaches should be prescribed under the explicit direction of Modified release antianginal drugs->2.6.2 Calcium-channel choice a specialist only. blockers->VERAPAMIL HYDROCHLORIDE

2.6 Nitrates, calcium-channel blockers, and other Joint formulary antianginal drugs->2.6.2 Calcium-channel Oral verapamil for cluster headaches should be prescribed under the explicit direction of Univer® choice blockers->VERAPAMIL HYDROCHLORIDE->Modified a specialist only. release 2.6 Nitrates, calcium-channel blockers, and other Joint formulary antianginal drugs->2.6.2 Calcium-channel Oral verapamil for cluster headaches should be prescribed under the explicit direction of Verapress MR® choice blockers->VERAPAMIL HYDROCHLORIDE->Modified a specialist only. release

2.6 Nitrates, calcium-channel blockers, and other Verapamil hydrochloride Not approved for antianginal drugs->2.6.2 Calcium-channel formulations [unlicensed] prescribing blockers->VERAPAMIL HYDROCHLORIDE

Specialist 2.6 Nitrates, calcium-channel blockers, and other Other antianginal drugs knowledge drugs antianginal drugs

Specialist 2.6 Nitrates, calcium-channel blockers, and other IVABRADINE TA267 http://www.nice.org.uk/TA267 knowledge drugs antianginal drugs->2.6.3 Other antianginal drugs

2.6 Nitrates, calcium-channel blockers, and other Specialist Procoralan® antianginal drugs->2.6.3 Other antianginal knowledge drugs drugs->IVABRADINE

Specialist 2.6 Nitrates, calcium-channel blockers, and other NICORANDIL knowledge drugs antianginal drugs->2.6.3 Other antianginal drugs

2.6 Nitrates, calcium-channel blockers, and other Specialist Nicorandil antianginal drugs->2.6.3 Other antianginal knowledge drugs drugs->NICORANDIL

2.6 Nitrates, calcium-channel blockers, and other Specialist Ikorel® antianginal drugs->2.6.3 Other antianginal knowledge drugs drugs->NICORANDIL

Specialist 2.6 Nitrates, calcium-channel blockers, and other RANOLAZINE knowledge drugs antianginal drugs->2.6.3 Other antianginal drugs

2.6 Nitrates, calcium-channel blockers, and other Specialist Ranexa® antianginal drugs->2.6.3 Other antianginal knowledge drugs drugs->RANOLAZINE

2.6 Nitrates, calcium-channel blockers, and other Not approved for CILOSTAZOL antianginal drugs->2.6.4 Peripheral vasodilators and TA223 http://www.nice.org.uk/TA223 prescribing related drugs 2.6 Nitrates, calcium-channel blockers, and other Not approved for Pletal® antianginal drugs->2.6.4 Peripheral vasodilators and prescribing related drugs->CILOSTAZOL

2.6 Nitrates, calcium-channel blockers, and other Not approved for INOSITOL NICOTINATE antianginal drugs->2.6.4 Peripheral vasodilators and TA223 http://www.nice.org.uk/TA223 prescribing related drugs

2.6 Nitrates, calcium-channel blockers, and other Not approved for Hexopal® antianginal drugs->2.6.4 Peripheral vasodilators and prescribing related drugs->INOSITOL NICOTINATE

2.6 Nitrates, calcium-channel blockers, and other Not approved for MOXISYLYTE antianginal drugs->2.6.4 Peripheral vasodilators and prescribing related drugs

2.6 Nitrates, calcium-channel blockers, and other Not approved for Opilon® antianginal drugs->2.6.4 Peripheral vasodilators and prescribing related drugs->MOXISYLYTE

2.6 Nitrates, calcium-channel blockers, and other Specialist NAFTIDROFURYL OXALATE antianginal drugs->2.6.4 Peripheral vasodilators and TA223 http://www.nice.org.uk/TA223 knowledge drugs related drugs

2.6 Nitrates, calcium-channel blockers, and other Specialist Naftidrofuryl antianginal drugs->2.6.4 Peripheral vasodilators and knowledge drugs related drugs->NAFTIDROFURYL OXALATE

2.6 Nitrates, calcium-channel blockers, and other Specialist Praxilene® antianginal drugs->2.6.4 Peripheral vasodilators and knowledge drugs related drugs->NAFTIDROFURYL OXALATE

2.6 Nitrates, calcium-channel blockers, and other Not approved for PENTOXIFYLLINE antianginal drugs->2.6.4 Peripheral vasodilators and TA223 http://www.nice.org.uk/TA223 prescribing related drugs

2.6 Nitrates, calcium-channel blockers, and other Not approved for Trental® antianginal drugs->2.6.4 Peripheral vasodilators and prescribing related drugs->PENTOXIFYLLINE

2.6 Nitrates, calcium-channel blockers, and other Other preparations used in Not approved for antianginal drugs->2.6.4 Peripheral vasodilators and peripheral vascular disease prescribing related drugs

2.6 Nitrates, calcium-channel blockers, and other Not approved for antianginal drugs->2.6.4 Peripheral vasodilators and Paroven® prescribing related drugs->Other preparations used in peripheral vascular disease Hospital only 2.7 Sympathomimetics->2.7.1 Inotropic DOBUTAMINE prescribing sympathomimetics

Hospital only 2.7 Sympathomimetics->2.7.1 Inotropic Dobutamine prescribing sympathomimetics->DOBUTAMINE

Hospital only 2.7 Sympathomimetics->2.7.1 Inotropic DOPAMINE HYDROCHLORIDE prescribing sympathomimetics

Hospital only 2.7 Sympathomimetics->2.7.1 Inotropic Dopamine prescribing sympathomimetics->DOPAMINE HYDROCHLORIDE

Not approved for 2.7 Sympathomimetics->2.7.1 Inotropic DOPEXAMINE HYDROCHLORIDE prescribing sympathomimetics

Not approved for 2.7 Sympathomimetics->2.7.1 Inotropic Dopacard® prescribing sympathomimetics->DOPEXAMINE HYDROCHLORIDE

Not approved for 2.7 Sympathomimetics->2.7.2 Vasoconstrictor EPHEDRINE HYDROCHLORIDE prescribing sympathomimetics

Not approved for 2.7 Sympathomimetics->2.7.2 Vasoconstrictor Ephedrine Hydrochloride prescribing sympathomimetics->EPHEDRINE HYDROCHLORIDE

Hospital only 2.7 Sympathomimetics->2.7.2 Vasoconstrictor METARAMINOL prescribing sympathomimetics

Hospital only 2.7 Sympathomimetics->2.7.2 Vasoconstrictor Metaraminol prescribing sympathomimetics->METARAMINOL

2.7 Sympathomimetics->2.7.2 Vasoconstrictor MIDODRINE HYDROCHLORIDE None sympathomimetics

2.7 Sympathomimetics->2.7.2 Vasoconstrictor Bramox® None sympathomimetics->MIDODRINE HYDROCHLORIDE

Hospital only 2.7 Sympathomimetics->2.7.2 Vasoconstrictor NORADRENALINE/NOREPINEPHRINE prescribing sympathomimetics

Hospital only 2.7 Sympathomimetics->2.7.2 Vasoconstrictor Noradrenaline/Norepinephrine prescribing sympathomimetics->NORADRENALINE/NOREPINEPHRINE

Hospital only 2.7 Sympathomimetics->2.7.2 Vasoconstrictor PHENYLEPHRINE HYDROCHLORIDE prescribing sympathomimetics

Hospital only 2.7 Sympathomimetics->2.7.2 Vasoconstrictor Phenylephrine prescribing sympathomimetics->PHENYLEPHRINE HYDROCHLORIDE

Hospital only 2.7 Sympathomimetics->2.7.3 Cardiopulmonary ADRENALINE/EPINEPHRINE prescribing resuscitation Adrenaline/Epinephrine 1 in Hospital only 2.7 Sympathomimetics->2.7.3 Cardiopulmonary 10 000, Dilute prescribing resuscitation->ADRENALINE/EPINEPHRINE

Hospital only 2.8 Anticoagulants and protamine->2.8.1 Parenteral Heparin prescribing anticoagulants

Hospital only 2.8 Anticoagulants and protamine->2.8.1 Parenteral HEPARIN prescribing anticoagulants->Heparin

Hospital only 2.8 Anticoagulants and protamine->2.8.1 Parenteral Heparin Sodium prescribing anticoagulants->Heparin->HEPARIN

Hospital only 2.8 Anticoagulants and protamine->2.8.1 Parenteral Heparin Calcium prescribing anticoagulants->Heparin->HEPARIN

Not approved for 2.8 Anticoagulants and protamine->2.8.1 Parenteral DALTEPARIN SODIUM prescribing anticoagulants->Low molecular weight heparins

2.8 Anticoagulants and protamine->2.8.1 Parenteral Not approved for Fragmin® anticoagulants->Low molecular weight prescribing heparins->DALTEPARIN SODIUM

Hospital only 2.8 Anticoagulants and protamine->2.8.1 Parenteral ENOXAPARIN SODIUM prescribing anticoagulants->Low molecular weight heparins

2.8 Anticoagulants and protamine->2.8.1 Parenteral Hospital only Clexane® anticoagulants->Low molecular weight prescribing heparins->ENOXAPARIN SODIUM

Hospital only 2.8 Anticoagulants and protamine->2.8.1 Parenteral TINZAPARIN SODIUM prescribing anticoagulants->Low molecular weight heparins

2.8 Anticoagulants and protamine->2.8.1 Parenteral Hospital only Innohep® anticoagulants->Low molecular weight prescribing heparins->TINZAPARIN SODIUM

Not approved for 2.8 Anticoagulants and protamine->2.8.1 Parenteral Heparinoids prescribing anticoagulants

Not approved for 2.8 Anticoagulants and protamine->2.8.1 Parenteral DANAPAROID SODIUM prescribing anticoagulants->Heparinoids

Not approved for 2.8 Anticoagulants and protamine->2.8.1 Parenteral Orgaran® prescribing anticoagulants->Heparinoids->DANAPAROID SODIUM

Not approved for 2.8 Anticoagulants and protamine->2.8.1 Parenteral Argatroban prescribing anticoagulants Not approved for 2.8 Anticoagulants and protamine->2.8.1 Parenteral ARGATROBAN MONOHYDRATE prescribing anticoagulants->Argatroban

2.8 Anticoagulants and protamine->2.8.1 Parenteral Not approved for Exembol® anticoagulants->Argatroban->ARGATROBAN prescribing MONOHYDRATE

Hospital only 2.8 Anticoagulants and protamine->2.8.1 Parenteral Hirudins prescribing anticoagulants The JPG agreed not to approve this medicine for use at the Homerton University Hospital Foundation Trust as the trust does not provide this specialist service. Hospital only 2.8 Anticoagulants and protamine->2.8.1 Parenteral BIVALIRUDIN TA230 http://www.nice.org.uk/TA230 prescribing anticoagulants->Hirudins The JPG supports CCG funding for the provision of this medicine at accredited specialist hospitals, provided that it is used in accordance to the relevant NICE Technology Appraisal.

The JPG agreed not to approve this medicine for use at the Homerton University Hospital Foundation Trust as the trust does not provide this specialist service. Hospital only 2.8 Anticoagulants and protamine->2.8.1 Parenteral Angiox® prescribing anticoagulants->Hirudins->BIVALIRUDIN The JPG supports CCG funding for the provision of this medicine at accredited specialist hospitals, provided that it is used in accordance to the relevant NICE Technology Appraisal.

Hospital only 2.8 Anticoagulants and protamine->2.8.1 Parenteral Heparin flushes prescribing anticoagulants

Hospital only 2.8 Anticoagulants and protamine->2.8.1 Parenteral Heparin Sodium prescribing anticoagulants->Heparin flushes

Hospital only 2.8 Anticoagulants and protamine->2.8.1 Parenteral Epoprostenol prescribing anticoagulants

Hospital only 2.8 Anticoagulants and protamine->2.8.1 Parenteral EPOPROSTENOL prescribing anticoagulants->Epoprostenol

Hospital only 2.8 Anticoagulants and protamine->2.8.1 Parenteral Flolan® prescribing anticoagulants->Epoprostenol->EPOPROSTENOL

2.8 Anticoagulants and protamine->2.8.1 Parenteral Veletri® None anticoagulants->Epoprostenol->EPOPROSTENOL

Hospital only 2.8 Anticoagulants and protamine->2.8.1 Parenteral Fondaparinux prescribing anticoagulants

Hospital only 2.8 Anticoagulants and protamine->2.8.1 Parenteral FONDAPARINUX SODIUM prescribing anticoagulants->Fondaparinux 2.8 Anticoagulants and protamine->2.8.1 Parenteral Fondaparinux Sodium None anticoagulants->Fondaparinux->FONDAPARINUX SODIUM

2.8 Anticoagulants and protamine->2.8.1 Parenteral Hospital only Arixtra® anticoagulants->Fondaparinux->FONDAPARINUX prescribing SODIUM

Specialist 2.8 Anticoagulants and protamine->2.8.2 Oral WARFARIN SODIUM knowledge drugs anticoagulants->Coumarins and phenindione

2.8 Anticoagulants and protamine->2.8.2 Oral Specialist Warfarin anticoagulants->Coumarins and knowledge drugs phenindione->WARFARIN SODIUM

2.8 Anticoagulants and protamine->2.8.2 Oral Warfarin sodium formulations Not approved for anticoagulants->Coumarins and [unlicensed] prescribing phenindione->WARFARIN SODIUM

Specialist 2.8 Anticoagulants and protamine->2.8.2 Oral ACENOCOUMAROL knowledge drugs anticoagulants->Coumarins and phenindione

2.8 Anticoagulants and protamine->2.8.2 Oral Acenocoumarol None anticoagulants->Coumarins and phenindione->ACENOCOUMAROL

2.8 Anticoagulants and protamine->2.8.2 Oral Specialist Sinthrome® anticoagulants->Coumarins and knowledge drugs phenindione->ACENOCOUMAROL

Specialist 2.8 Anticoagulants and protamine->2.8.2 Oral PHENINDIONE knowledge drugs anticoagulants->Coumarins and phenindione

2.8 Anticoagulants and protamine->2.8.2 Oral Specialist Phenindione anticoagulants->Coumarins and knowledge drugs phenindione->PHENINDIONE

A Shared Care Guideline (SCG) may be available. Where it is, obtain guideline from secondary care and if happy to prescribe in accordance with the guidelines, take over Shared care 2.8 Anticoagulants and protamine->2.8.2 Oral the agreed responsibilities including prescribing. Dabigatran etexilate guidelines anticoagulants

Click here to access shared care guidelines . A Shared Care Guideline (SCG) may be available. Where it is, obtain guideline from secondary care and if happy to prescribe in accordance with the guidelines, take over Shared care 2.8 Anticoagulants and protamine->2.8.2 Oral the agreed responsibilities including prescribing. DABIGATRAN ETEXILATE TA327 http://www.nice.org.uk/TA327 guidelines anticoagulants->Dabigatran etexilate

Click here to access shared care guidelines .

A Shared Care Guideline (SCG) may be available. Where it is, obtain guideline from secondary care and if happy to prescribe in accordance with the guidelines, take over 2.8 Anticoagulants and protamine->2.8.2 Oral Shared care the agreed responsibilities including prescribing. Pradaxa® anticoagulants->Dabigatran etexilate->DABIGATRAN guidelines ETEXILATE Click here to access shared care guidelines .

Shared care 2.8 Anticoagulants and protamine->2.8.2 Oral Apixaban guidelines anticoagulants

Click here to access shared care guidelines . A Shared Care Guideline (SCG) may be available. Where it is, obtain guideline from secondary care and if happy to prescribe in accordance with the guidelines, take over Shared care 2.8 Anticoagulants and protamine->2.8.2 Oral the agreed responsibilities including prescribing. APIXABAN TA275 http://www.nice.org.uk/TA275 guidelines anticoagulants->Apixaban

Click here to access shared care guidelines .

Shared care 2.8 Anticoagulants and protamine->2.8.2 Oral Edoxaban guidelines anticoagulants

Shared care 2.8 Anticoagulants and protamine->2.8.2 Oral EDOXABAN TA355 http://www.nice.org.uk/TA355 guidelines anticoagulants->Edoxaban

Shared care 2.8 Anticoagulants and protamine->2.8.2 Oral EDOXABAN guidelines anticoagulants->Edoxaban

Shared care 2.8 Anticoagulants and protamine->2.8.2 Oral Lixiana® guidelines anticoagulants->Edoxaban->EDOXABAN

Click here to access shared care guidelines . A Shared Care Guideline (SCG) may be available. Where it is, obtain guideline from secondary care and if happy to prescribe in accordance with the guidelines, take over Shared care 2.8 Anticoagulants and protamine->2.8.2 Oral the agreed responsibilities including prescribing. RIVAROXABAN TA335 http://www.nice.org.uk/TA335 guidelines anticoagulants->Rivaroxaban

Click here to access shared care guidelines .

Click here to access shared care guidelines . A Shared Care Guideline (SCG) may be available. Where it is, obtain guideline from secondary care and if happy to prescribe in accordance with the guidelines, take over Shared care 2.8 Anticoagulants and protamine->2.8.2 Oral the agreed responsibilities including prescribing. Xarelto® guidelines anticoagulants->Rivaroxaban->RIVAROXABAN

Click here to access shared care guidelines .

Hospital only Protamine sulfate 2.8 Anticoagulants and protamine prescribing

Hospital only 2.8 Anticoagulants and protamine->2.8.3 Protamine PROTAMINE SULFATE prescribing sulfate

Hospital only 2.8 Anticoagulants and protamine->2.8.3 Protamine Protamine Sulfate prescribing sulfate->PROTAMINE SULFATE

IDARUCIZUMAB None 2.8 Anticoagulants and protamine->2.8.4 Idarucizumab

2.8 Anticoagulants and protamine->2.8.4 Praxbind® None Idarucizumab->IDARUCIZUMAB

The JPG agreed not to approve this medicine for use at the Homerton University Hospital only ABCIXIMAB 2.9 Antiplatelet drugs prescribing Hospital Foundation Trust as the trust does not provide this specialist service.

The JPG agreed not to approve this medicine for use at the Homerton University Hospital only ReoPro® 2.9 Antiplatelet drugs->ABCIXIMAB prescribing Hospital Foundation Trust as the trust does not provide this specialist service.

Joint formulary ASPIRIN (antiplatelet) 2.9 Antiplatelet drugs choice

Joint formulary Aspirin 2.9 Antiplatelet drugs->ASPIRIN (antiplatelet) choice

Not approved for Nu-Seals® Aspirin 2.9 Antiplatelet drugs->ASPIRIN (antiplatelet) prescribing

CANGRELOR None 2.9 Antiplatelet drugs

Kengrexal® None 2.9 Antiplatelet drugs->CANGRELOR

Joint formulary CLOPIDOGREL 2.9 Antiplatelet drugs TA210 http://www.nice.org.uk/TA210 choice

Joint formulary Clopidogrel 2.9 Antiplatelet drugs->CLOPIDOGREL choice Not approved for Plavix® 2.9 Antiplatelet drugs->CLOPIDOGREL Prescribe generically prescribing

Joint formulary Parenteral dipyridamole should only be prescribed in secondary care by or under the DIPYRIDAMOLE 2.9 Antiplatelet drugs TA210 http://www.nice.org.uk/TA210 choice explicit direction of a specialist

Joint formulary Dipyridamole 2.9 Antiplatelet drugs->DIPYRIDAMOLE choice

Joint formulary Parenteral dipyridamole should only be prescribed in secondary care by or under the Persantin® 2.9 Antiplatelet drugs->DIPYRIDAMOLE choice explicit direction of a specialist

Joint formulary Modified release 2.9 Antiplatelet drugs->DIPYRIDAMOLE choice

Joint formulary 2.9 Antiplatelet drugs->DIPYRIDAMOLE->Modified Persantin® Retard choice release

Joint formulary With aspirin 2.9 Antiplatelet drugs->DIPYRIDAMOLE choice

Joint formulary Asasantin® Retard 2.9 Antiplatelet drugs->DIPYRIDAMOLE->With aspirin choice

The JPG agreed not to approve this medicine for use at the Homerton University Hospital Hospital only EPTIFIBATIDE 2.9 Antiplatelet drugs prescribing Foundation Trust as the trust does not provide this specialist service.

The JPG agreed not to approve this medicine for use at the Homerton University Hospital Hospital only Integrilin® 2.9 Antiplatelet drugs->EPTIFIBATIDE prescribing Foundation Trust as the trust does not provide this specialist service.

Specialist PRASUGREL 2.9 Antiplatelet drugs TA317 http://www.nice.org.uk/TA317 knowledge drugs

Specialist Efient® 2.9 Antiplatelet drugs->PRASUGREL knowledge drugs

Specialist TICAGRELOR 2.9 Antiplatelet drugs TA420 http://www.nice.org.uk/TA420 knowledge drugs

Specialist TICAGRELOR 2.9 Antiplatelet drugs TA236 http://www.nice.org.uk/TA236 knowledge drugs

Specialist Brilique® 2.9 Antiplatelet drugs->TICAGRELOR knowledge drugs The JPG agreed not to approve this medicine for use at the Homerton University Hospital Hospital only TIROFIBAN 2.9 Antiplatelet drugs prescribing Foundation Trust as the trust does not provide this specialist service.

The JPG agreed not to approve this medicine for use at the Homerton University Hospital Hospital only Aggrastat® 2.9 Antiplatelet drugs->TIROFIBAN prescribing Foundation Trust as the trust does not provide this specialist service.

Hospital only 2.10 Stable angina, acute coronary syndromes, and ALTEPLASE TA264 http://www.nice.org.uk/TA264 prescribing fibrinolysis->2.10.2 Fibrinolytic drugs

Hospital only 2.10 Stable angina, acute coronary syndromes, and Actilyse® prescribing fibrinolysis->2.10.2 Fibrinolytic drugs->ALTEPLASE

Hospital only 2.10 Stable angina, acute coronary syndromes, and Actilyse Cathflo® prescribing fibrinolysis->2.10.2 Fibrinolytic drugs->ALTEPLASE

Not approved for 2.10 Stable angina, acute coronary syndromes, and RETEPLASE prescribing fibrinolysis->2.10.2 Fibrinolytic drugs

Not approved for 2.10 Stable angina, acute coronary syndromes, and Rapilysin® prescribing fibrinolysis->2.10.2 Fibrinolytic drugs->RETEPLASE

Hospital only 2.10 Stable angina, acute coronary syndromes, and STREPTOKINASE prescribing fibrinolysis->2.10.2 Fibrinolytic drugs

Hospital only 2.10 Stable angina, acute coronary syndromes, and Streptase® prescribing fibrinolysis->2.10.2 Fibrinolytic drugs->STREPTOKINASE

Hospital only 2.10 Stable angina, acute coronary syndromes, and TENECTEPLASE prescribing fibrinolysis->2.10.2 Fibrinolytic drugs

Hospital only 2.10 Stable angina, acute coronary syndromes, and Metalyse® prescribing fibrinolysis->2.10.2 Fibrinolytic drugs->TENECTEPLASE

Hospital only 2.10 Stable angina, acute coronary syndromes, and UROKINASE prescribing fibrinolysis->2.10.2 Fibrinolytic drugs

Hospital only 2.10 Stable angina, acute coronary syndromes, and Urokinase prescribing fibrinolysis->2.10.2 Fibrinolytic drugs->UROKINASE

Hospital only 2.10 Stable angina, acute coronary syndromes, and Syner-KINASE® prescribing fibrinolysis->2.10.2 Fibrinolytic drugs->UROKINASE

Not approved for ETAMSYLATE 2.11 Antifibrinolytic drugs and haemostatics prescribing

Not approved for 2.11 Antifibrinolytic drugs and Dicynene® prescribing haemostatics->ETAMSYLATE Joint formulary Tranexamic acidinjection/infusionshould only be prescribed in secondary care by or TRANEXAMIC ACID 2.11 Antifibrinolytic drugs and haemostatics choice under the explicit direction of a specialist.

Joint formulary 2.11 Antifibrinolytic drugs and Tranexamic acidinjection/infusionshould only be prescribed in secondary care by or Tranexamic acid choice haemostatics->TRANEXAMIC ACID under the explicit direction of a specialist.

Joint formulary 2.11 Antifibrinolytic drugs and Cyklokapron® choice haemostatics->TRANEXAMIC ACID

Hospital only 2.11 Antifibrinolytic drugs and Cyklokapron® prescribing haemostatics->TRANEXAMIC ACID

Not approved for 2.11 Antifibrinolytic drugs and DRIED PROTHROMBIN COMPLEX prescribing haemostatics->Blood-related products

Hospital only 2.11 Antifibrinolytic drugs and FACTOR VIIa (RECOMBINANT) prescribing haemostatics->Blood-related products

Not approved for 2.11 Antifibrinolytic drugs and FACTOR VIII FRACTION, DRIED prescribing haemostatics->Blood-related products

FACTOR VIII INHIBITOR BYPASSING Not approved for 2.11 Antifibrinolytic drugs and FRACTION prescribing haemostatics->Blood-related products

Not approved for 2.11 Antifibrinolytic drugs and FACTOR IX FRACTION, DRIED prescribing haemostatics->Blood-related products

Not approved for 2.11 Antifibrinolytic drugs and FACTOR XIII FRACTION, DRIED prescribing haemostatics->Blood-related products

Not approved for 2.11 Antifibrinolytic drugs and FIBRINOGEN, DRIED prescribing haemostatics->Blood-related products

Hospital only 2.11 Antifibrinolytic drugs and FRESH FROZEN PLASMA prescribing haemostatics->Blood-related products

Not approved for 2.11 Antifibrinolytic drugs and PROTEIN C CONCENTRATE prescribing haemostatics->Blood-related products

ATORVASTATIN None 2.12 Lipid-regulating drugs->Statins

Joint formulary Atorvastatin 2.12 Lipid-regulating drugs->Statins->ATORVASTATIN choice

Not approved for Lipitor® 2.12 Lipid-regulating drugs->Statins->ATORVASTATIN prescribing

Not approved for FLUVASTATIN 2.12 Lipid-regulating drugs->Statins prescribing Not approved for Fluvastatin 2.12 Lipid-regulating drugs->Statins->FLUVASTATIN prescribing

Not approved for Lescol® 2.12 Lipid-regulating drugs->Statins->FLUVASTATIN prescribing

Not approved for Modified release 2.12 Lipid-regulating drugs->Statins->FLUVASTATIN prescribing

Not approved for 2.12 Lipid-regulating Fluvastatin prescribing drugs->Statins->FLUVASTATIN->Modified release

Not approved for 2.12 Lipid-regulating Lescol® XL prescribing drugs->Statins->FLUVASTATIN->Modified release

Joint formulary PRAVASTATIN SODIUM 2.12 Lipid-regulating drugs->Statins choice

Joint formulary 2.12 Lipid-regulating drugs->Statins->PRAVASTATIN Pravastatin choice SODIUM

Not approved for 2.12 Lipid-regulating drugs->Statins->PRAVASTATIN Lipostat® prescribing SODIUM

Not approved for ROSUVASTATIN 2.12 Lipid-regulating drugs->Statins prescribing

Not approved for Crestor® 2.12 Lipid-regulating drugs->Statins->ROSUVASTATIN prescribing

Joint formulary SIMVASTATIN 2.12 Lipid-regulating drugs->Statins choice

Joint formulary Simvastatin 2.12 Lipid-regulating drugs->Statins->SIMVASTATIN choice

Not approved for Zocor® 2.12 Lipid-regulating drugs->Statins->SIMVASTATIN prescribing

Not approved for With ezetimibe 2.12 Lipid-regulating drugs->Statins->SIMVASTATIN prescribing

Not approved for 2.12 Lipid-regulating Inegy® prescribing drugs->Statins->SIMVASTATIN->With ezetimibe

2.12 Lipid-regulating Cholib® None drugs->Statins->SIMVASTATIN->With fenofibrate

ALIROCUMAB None 2.12 Lipid-regulating drugs->Alirocumab TA393 http://www.nice.org.uk/TA393 Praluent® None 2.12 Lipid-regulating drugs->Alirocumab->ALIROCUMAB

Not approved for COLESEVELAM HYDROCHLORIDE 2.12 Lipid-regulating drugs->Bile acid sequestrants prescribing

Not approved for 2.12 Lipid-regulating drugs->Bile acid Cholestagel® prescribing sequestrants->COLESEVELAM HYDROCHLORIDE

Joint formulary COLESTYRAMINE 2.12 Lipid-regulating drugs->Bile acid sequestrants choice

Joint formulary 2.12 Lipid-regulating drugs->Bile acid Colestyramine choice sequestrants->COLESTYRAMINE

Joint formulary 2.12 Lipid-regulating drugs->Bile acid Questran® choice sequestrants->COLESTYRAMINE

Not approved for 2.12 Lipid-regulating drugs->Bile acid Questran Light® prescribing sequestrants->COLESTYRAMINE

Not approved for COLESTIPOL HYDROCHLORIDE 2.12 Lipid-regulating drugs->Bile acid sequestrants prescribing

Not approved for 2.12 Lipid-regulating drugs->Bile acid Colestid® prescribing sequestrants->COLESTIPOL HYDROCHLORIDE

EVOLOCUMAB None 2.12 Lipid-regulating drugs->Evolocumab TA394 http://www.nice.org.uk/TA394

2.12 Lipid-regulating Repatha® None drugs->Evolocumab->EVOLOCUMAB

Joint formulary Ezetimibe 2.12 Lipid-regulating drugs choice

Joint formulary EZETIMIBE 2.12 Lipid-regulating drugs->Ezetimibe TA385 http://www.nice.org.uk/TA385 choice

Not approved for Ezetrol® 2.12 Lipid-regulating drugs->Ezetimibe->EZETIMIBE Prescribe generically. prescribing

Not approved for With simvastatin 2.12 Lipid-regulating drugs->Ezetimibe->EZETIMIBE prescribing

Joint formulary BEZAFIBRATE 2.12 Lipid-regulating drugs->Fibrates choice

Joint formulary Bezafibrate 2.12 Lipid-regulating drugs->Fibrates->BEZAFIBRATE choice Joint formulary Bezalip® 2.12 Lipid-regulating drugs->Fibrates->BEZAFIBRATE choice

Joint formulary Modified release 2.12 Lipid-regulating drugs->Fibrates->BEZAFIBRATE choice

Joint formulary 2.12 Lipid-regulating Bezafibrate choice drugs->Fibrates->BEZAFIBRATE->Modified release

Joint formulary 2.12 Lipid-regulating Bezalip® Mono choice drugs->Fibrates->BEZAFIBRATE->Modified release

Not approved for CIPROFIBRATE 2.12 Lipid-regulating drugs->Fibrates prescribing

Not approved for Ciprofibrate 2.12 Lipid-regulating drugs->Fibrates->CIPROFIBRATE prescribing

Not approved for FENOFIBRATE 2.12 Lipid-regulating drugs->Fibrates prescribing

Not approved for Fenofibrate 2.12 Lipid-regulating drugs->Fibrates->FENOFIBRATE prescribing

Not approved for Lipantil® 2.12 Lipid-regulating drugs->Fibrates->FENOFIBRATE prescribing

Not approved for Supralip® 160 2.12 Lipid-regulating drugs->Fibrates->FENOFIBRATE prescribing

Not approved for GEMFIBROZIL 2.12 Lipid-regulating drugs->Fibrates prescribing

Not approved for Gemfibrozil 2.12 Lipid-regulating drugs->Fibrates->GEMFIBROZIL prescribing

Not approved for Lopid® 2.12 Lipid-regulating drugs->Fibrates->GEMFIBROZIL prescribing

LOMITAPIDE None 2.12 Lipid-regulating drugs->Lomitapide

Lojuxta None 2.12 Lipid-regulating drugs->Lomitapide->LOMITAPIDE

Not approved for Nicotinic acid group 2.12 Lipid-regulating drugs prescribing

Not approved for ACIPIMOX 2.12 Lipid-regulating drugs->Nicotinic acid group prescribing Not approved for 2.12 Lipid-regulating drugs->Nicotinic acid Olbetam® prescribing group->ACIPIMOX

Not approved for NICOTINIC ACID 2.12 Lipid-regulating drugs->Nicotinic acid group prescribing

Not approved for 2.12 Lipid-regulating drugs->Nicotinic acid Modified release prescribing group->NICOTINIC ACID

Not approved for 2.12 Lipid-regulating drugs->Nicotinic acid Niaspan® prescribing group->NICOTINIC ACID->Modified release

Specialist Omega-3 fatty acid compounds 2.12 Lipid-regulating drugs knowledge drugs

Specialist 2.12 Lipid-regulating drugs->Omega-3 fatty acid OMEGA-3-ACID ETHYL ESTERS knowledge drugs compounds

Specialist 2.12 Lipid-regulating drugs->Omega-3 fatty acid Omacor® knowledge drugs compounds->OMEGA-3-ACID ETHYL ESTERS

Specialist 2.12 Lipid-regulating drugs->Omega-3 fatty acid Prestylon® knowledge drugs compounds->OMEGA-3-ACID ETHYL ESTERS

Not approved for SODIUM TETRADECYL SULFATE 2.13 Local sclerosants prescribing

Fibrovein® None 2.13 Local sclerosants->SODIUM TETRADECYL SULFATE